
@article{aringhieri2018,
	title = {Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences},
	author = {Aringhieri, Stefano and Carli, Marco and Kolachalam, Shivakumar and Verdesca, Valeria and Cini, Enrico and Rossi, Mario and McCormick, Peter J. and Corsini, Giovanni U. and Maggio, Roberto and Scarselli, Marco},
	year = {2018},
	month = {12},
	date = {2018-12},
	journal = {Pharmacology & Therapeutics},
	pages = {20--41},
	volume = {192},
	doi = {10.1016/j.pharmthera.2018.06.012},
	note = {PMID: 29953902},
	langid = {eng}
}

@article{grattan2015,
	title = {60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis},
	author = {Grattan, David R.},
	year = {2015},
	month = {08},
	date = {2015-08},
	journal = {The Journal of Endocrinology},
	pages = {T101--122},
	volume = {226},
	number = {2},
	doi = {10.1530/JOE-15-0213},
	note = {PMID: 26101377
PMCID: PMC4515538},
	langid = {eng}
}

@article{mccutcheon2019,
	title = {Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms},
	author = {McCutcheon, Robert A. and Abi-Dargham, Anissa and Howes, Oliver D.},
	year = {2019},
	month = {03},
	date = {2019-03},
	journal = {Trends in Neurosciences},
	pages = {205--220},
	volume = {42},
	number = {3},
	doi = {10.1016/j.tins.2018.12.004},
	note = {PMID: 30621912
PMCID: PMC6401206},
	langid = {eng}
}

@article{peters2016,
	title = {Cortico-Striatal-Thalamic Loop Circuits of the Salience Network: A Central Pathway in Psychiatric Disease and Treatment},
	author = {Peters, Sarah K. and Dunlop, Katharine and Downar, Jonathan},
	year = {2016},
	month = {12},
	date = {2016-12-27},
	journal = {Frontiers in Systems Neuroscience},
	volume = {10},
	doi = {10.3389/fnsys.2016.00104},
	url = {http://journal.frontiersin.org/article/10.3389/fnsys.2016.00104/full}
}

@article{menegas2018,
	title = {Dopamine neurons projecting to the posterior striatum reinforce avoidance of threatening stimuli},
	author = {Menegas, William and Akiti, Korleki and Amo, Ryunosuke and Uchida, Naoshige and Watabe-Uchida, Mitsuko},
	year = {2018},
	month = {10},
	date = {2018-10},
	journal = {Nature Neuroscience},
	pages = {1421--1430},
	volume = {21},
	number = {10},
	doi = {10.1038/s41593-018-0222-1},
	note = {PMID: 30177795
PMCID: PMC6160326},
	langid = {eng}
}

@article{fornito2013,
	title = {Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis},
	author = {Fornito, Alex and Harrison, Ben J. and Goodby, Emmeline and Dean, Anna and Ooi, Cinly and Nathan, Pradeep J. and Lennox, Belinda R. and Jones, Peter B. and Suckling, John and Bullmore, Edward T.},
	year = {2013},
	month = {11},
	date = {2013-11},
	journal = {JAMA psychiatry},
	pages = {1143--1151},
	volume = {70},
	number = {11},
	doi = {10.1001/jamapsychiatry.2013.1976},
	note = {PMID: 24005188},
	langid = {eng}
}

@article{maia2017,
	title = {An Integrative Perspective on the Role of Dopamine in Schizophrenia},
	author = {Maia, Tiago V. and Frank, Michael J.},
	year = {2017},
	month = {01},
	date = {2017-01-01},
	journal = {Biological Psychiatry},
	pages = {52--66},
	volume = {81},
	number = {1},
	doi = {10.1016/j.biopsych.2016.05.021},
	note = {PMID: 27452791
PMCID: PMC5486232},
	langid = {eng}
}

@article{hall1994,
	title = {Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain},
	author = {Hall, {Håkan} and Sedvall, {Göran} and Magnusson, Olle and Kopp, Jutta and Halldin, Christer and Farde, Lars},
	year = {1994},
	month = {12},
	date = {1994-12},
	journal = {Neuropsychopharmacology},
	pages = {245--256},
	volume = {11},
	number = {4},
	doi = {10.1038/sj.npp.1380111},
	url = {http://www.nature.com/articles/1380111},
	langid = {en}
}

@article{camps1989,
	title = {Dopamine receptors in human brain: autoradiographic distribution of D2 sites},
	author = {Camps, M. and {Cortés}, R. and Gueye, B. and Probst, A. and Palacios, J. M.},
	year = {1989},
	date = {1989},
	journal = {Neuroscience},
	pages = {275--290},
	volume = {28},
	number = {2},
	doi = {10.1016/0306-4522(89)90179-6},
	note = {PMID: 2522167},
	langid = {eng}
}

@article{martel2020,
	title = {Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia},
	author = {Martel, Jean Claude and Gatti McArthur, Silvia},
	year = {2020},
	month = {07},
	date = {2020-07-14},
	journal = {Frontiers in Pharmacology},
	pages = {1003},
	volume = {11},
	doi = {10.3389/fphar.2020.01003},
	url = {https://www.frontiersin.org/article/10.3389/fphar.2020.01003/full}
}

@article{farde1992,
	title = {Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects},
	author = {Farde, L. and {Nordström}, A. L. and Wiesel, F. A. and Pauli, S. and Halldin, C. and Sedvall, G.},
	year = {1992},
	month = {07},
	date = {1992-07},
	journal = {Archives of General Psychiatry},
	pages = {538--544},
	volume = {49},
	number = {7},
	doi = {10.1001/archpsyc.1992.01820070032005},
	note = {PMID: 1352677},
	langid = {eng}
}

@article{miller2009,
	title = {Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I},
	author = {Miller, R.},
	year = {2009},
	month = {12},
	date = {2009-12},
	journal = {Current Neuropharmacology},
	pages = {302--314},
	volume = {7},
	number = {4},
	doi = {10.2174/157015909790031229},
	note = {PMID: 20514210
PMCID: PMC2811864},
	langid = {eng}
}

@article{sawaguchi1991,
	title = {D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory},
	author = {Sawaguchi, Toshiyuki and Goldman-Rakic, Patricia S.},
	year = {1991},
	month = {02},
	date = {1991-02-22},
	journal = {Science},
	pages = {947--950},
	volume = {251},
	number = {4996},
	doi = {10.1126/science.1825731},
	url = {https://www.science.org/doi/10.1126/science.1825731},
	langid = {en}
}

@article{okubo1997,
	title = {Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET},
	author = {Okubo, Yoshiro and Suhara, Tetsuya and Suzuki, Kazutoshi and Kobayashi, Kaoru and Inoue, Osamu and Terasaki, Omi and Someya, Yasuhiro and Sassa, Takeshi and Sudo, Yasuhiko and Matsushima, Eisuke and Iyo, Masaomi and Tateno, Yukio and Toru, Michio},
	year = {1997},
	month = {02},
	date = {1997-02},
	journal = {Nature},
	pages = {634--636},
	volume = {385},
	number = {6617},
	doi = {10.1038/385634a0},
	url = {http://www.nature.com/articles/385634a0},
	langid = {en}
}

@article{abidargham2002,
	title = {Prefrontal dopamine D1 receptors and working memory in schizophrenia},
	author = {Abi-Dargham, Anissa and Mawlawi, Osama and Lombardo, Ilise and Gil, Roberto and Martinez, Diana and Huang, Yiyun and Hwang, Dah-Ren and Keilp, John and Kochan, Lisa and Van Heertum, Ronald and Gorman, Jack M. and Laruelle, Marc},
	year = {2002},
	month = {05},
	date = {2002-05-01},
	journal = {The Journal of Neuroscience: The Official Journal of the Society for Neuroscience},
	pages = {3708--3719},
	volume = {22},
	number = {9},
	doi = {20026302},
	note = {PMID: 11978847
PMCID: PMC6758376},
	langid = {eng}
}

@article{andersen1992,
	title = {NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists},
	author = {Andersen, Peter H. and {Grønvald}, Frederik C. and Hohlweg, Rolf and Hansen, Louis B. and Guddal, Erling and Braestrup, Claus and Nielsen, Erik B.},
	year = {1992},
	month = {08},
	date = {1992-08},
	journal = {European Journal of Pharmacology},
	pages = {45--52},
	volume = {219},
	number = {1},
	doi = {10.1016/0014-2999(92)90578-R},
	url = {https://linkinghub.elsevier.com/retrieve/pii/001429999290578R},
	langid = {en}
}

@article{aoyama2014,
	title = {Clozapine ameliorates epigenetic and behavioral abnormalities induced by phencyclidine through activation of dopamine D1 receptor},
	author = {Aoyama, Yuki and Mouri, Akihiro and Toriumi, Kazuya and Koseki, Takenao and Narusawa, Shiho and Ikawa, Natsumi and Mamiya, Takayoshi and Nagai, Taku and Yamada, Kiyofumi and Nabeshima, Toshitaka},
	year = {2014},
	month = {05},
	date = {2014-05},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {723--737},
	volume = {17},
	number = {05},
	doi = {10.1017/S1461145713001466},
	url = {https://academic.oup.com/ijnp/article-lookup/doi/10.1017/S1461145713001466},
	langid = {en}
}

@article{tauscher2004,
	title = {Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics},
	author = {Tauscher, Johannes and Hussain, Tabasum and Agid, Ofer and Verhoeff, N. Paul L. G. and Wilson, Alan A. and Houle, Sylvain and Remington, Gary and Zipursky, Robert B. and Kapur, Shitij},
	year = {2004},
	month = {09},
	date = {2004-09},
	journal = {The American Journal of Psychiatry},
	pages = {1620--1625},
	volume = {161},
	number = {9},
	doi = {10.1176/appi.ajp.161.9.1620},
	note = {PMID: 15337652},
	langid = {eng}
}

@article{castner2000,
	title = {Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation},
	author = {Castner, S. A. and Williams, G. V. and Goldman-Rakic, P. S.},
	year = {2000},
	month = {03},
	date = {2000-03-17},
	journal = {Science (New York, N.Y.)},
	pages = {2020--2022},
	volume = {287},
	number = {5460},
	doi = {10.1126/science.287.5460.2020},
	note = {PMID: 10720329},
	langid = {eng}
}

@article{girgis2016,
	title = {A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia},
	author = {Girgis, Ragy R. and Van Snellenberg, Jared X. and Glass, Andrew and Kegeles, Lawrence S. and Thompson, Judy L. and Wall, Melanie and Cho, Raymond Y. and Carter, Cameron S. and Slifstein, Mark and Abi-Dargham, Anissa and Lieberman, Jeffrey A.},
	year = {2016},
	month = {05},
	date = {2016-05},
	journal = {Journal of Psychopharmacology (Oxford, England)},
	pages = {428--435},
	volume = {30},
	number = {5},
	doi = {10.1177/0269881116636120},
	note = {PMID: 26966119},
	langid = {eng}
}

@article{salmi2004,
	title = {Dihydrexidine--the first full dopamine D1 receptor agonist},
	author = {Salmi, Peter and Isacson, Ruben and Kull, {Björn}},
	year = {2004},
	date = {2004},
	journal = {CNS drug reviews},
	pages = {230--242},
	volume = {10},
	number = {3},
	doi = {10.1111/j.1527-3458.2004.tb00024.x},
	note = {PMID: 15492773
PMCID: PMC6741759},
	langid = {eng}
}

@article{gurevich1999,
	title = {Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons},
	author = {Gurevich, E. V. and Joyce, J. N.},
	year = {1999},
	month = {01},
	date = {1999-01},
	journal = {Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology},
	pages = {60--80},
	volume = {20},
	number = {1},
	doi = {10.1016/S0893-133X(98)00066-9},
	note = {PMID: 9885786},
	langid = {eng}
}

@article{lahti1998,
	title = {Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia},
	author = {Lahti, A. C. and Weiler, M. and Carlsson, A. and Tamminga, C. A.},
	year = {1998},
	date = {1998},
	journal = {Journal of Neural Transmission (Vienna, Austria: 1996)},
	pages = {719--734},
	volume = {105},
	number = {6-7},
	doi = {10.1007/s007020050091},
	note = {PMID: 9826114},
	langid = {eng}
}

@article{lacroix2006,
	title = {Selective dopamine D3 receptor antagonists enhance cortical acetylcholine levels measured with high-performance liquid chromatography/tandem mass spectrometry without anti-cholinesterases},
	author = {Lacroix, Laurent P. and Ceolin, Laura and Zocchi, Alessandro and Varnier, Giorgia and Garzotti, Marco and Curcuruto, Ornella and Heidbreder, Christian A.},
	year = {2006},
	month = {10},
	date = {2006-10-15},
	journal = {Journal of Neuroscience Methods},
	pages = {25--31},
	volume = {157},
	number = {1},
	doi = {10.1016/j.jneumeth.2006.03.017},
	note = {PMID: 16697046},
	langid = {eng}
}

@article{nakajima2013,
	title = {The potential role of dopamine D₃ receptor neurotransmission in cognition},
	author = {Nakajima, Shinichiro and Gerretsen, Philip and Takeuchi, Hiroyoshi and Caravaggio, Fernando and Chow, Tiffany and Le Foll, Bernard and Mulsant, Benoit and Pollock, Bruce and Graff-Guerrero, Ariel},
	year = {2013},
	month = {08},
	date = {2013-08},
	journal = {European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology},
	pages = {799--813},
	volume = {23},
	number = {8},
	doi = {10.1016/j.euroneuro.2013.05.006},
	note = {PMID: 23791072
PMCID: PMC3748034},
	langid = {eng}
}

@article{baba2015,
	title = {Blonanserin extensively occupies rat dopamine D3 receptors at antipsychotic dose range},
	author = {Baba, Satoko and Enomoto, Takeshi and Horisawa, Tomoko and Hashimoto, Takashi and Ono, Michiko},
	year = {2015},
	month = {03},
	date = {2015-03},
	journal = {Journal of Pharmacological Sciences},
	pages = {326--331},
	volume = {127},
	number = {3},
	doi = {10.1016/j.jphs.2015.01.007},
	note = {PMID: 25837930},
	langid = {eng}
}

@article{huang2019,
	title = {The Role of Dopamine D3 Receptor Partial Agonism in Cariprazine-Induced Neurotransmitter Efflux in Rat Hippocampus and Nucleus Accumbens},
	author = {Huang, Mei and He, Wenqi and Kiss, {Béla} and Farkas, Bence and Adham, Nika and Meltzer, Herbert Y.},
	year = {2019},
	month = {11},
	date = {2019-11},
	journal = {The Journal of Pharmacology and Experimental Therapeutics},
	pages = {517--525},
	volume = {371},
	number = {2},
	doi = {10.1124/jpet.119.259879},
	note = {PMID: 31511365},
	langid = {eng}
}

@article{bolonna2005,
	title = {Partial agonism and schizophrenia},
	author = {Bolonna, A. A. and Kerwin, R. W.},
	year = {2005},
	month = {01},
	date = {2005-01},
	journal = {British Journal of Psychiatry},
	pages = {7--10},
	volume = {186},
	number = {1},
	doi = {10.1192/bjp.186.1.7},
	url = {https://www.cambridge.org/core/product/identifier/S0007125000230286/type/journal_article},
	langid = {en}
}

@article{sanyal1997,
	title = {Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action},
	author = {Sanyal, S. and Van Tol, H. H.},
	year = {1997},
	month = {04},
	date = {1997-04},
	journal = {Journal of Psychiatric Research},
	pages = {219--232},
	volume = {31},
	number = {2},
	doi = {10.1016/s0022-3956(96)00039-8},
	note = {PMID: 9278187},
	langid = {eng}
}

@article{seeman1993,
	title = {Dopamine D4 receptors elevated in schizophrenia},
	author = {Seeman, Philip and Guan, Hong-Chang and Van Tol, Hubert H. M.},
	year = {1993},
	month = {09},
	date = {1993-09},
	journal = {Nature},
	pages = {441--445},
	volume = {365},
	number = {6445},
	doi = {10.1038/365441a0},
	url = {http://www.nature.com/articles/365441a0},
	langid = {en}
}

@article{mulcrone1996,
	title = {No difference in the expression of the D4 gene in post-mortem frontal cortex from controls and schizophrenics},
	author = {Mulcrone, J. and Kerwin, R.W.},
	year = {1996},
	month = {11},
	date = {1996-11},
	journal = {Neuroscience Letters},
	pages = {163--166},
	volume = {219},
	number = {3},
	doi = {10.1016/S0304-3940(96)13191-8},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0304394096131918},
	langid = {en}
}

@article{hwu1998,
	title = {Dopamine D4 receptor gene polymorphisms and neuroleptic response in schizophrenia},
	author = {Hwu, H. G. and Hong, C. J. and Lee, Y. L. and Lee, P. C. and Lee, S. F.},
	year = {1998},
	month = {09},
	date = {1998-09-15},
	journal = {Biological Psychiatry},
	pages = {483--487},
	volume = {44},
	number = {6},
	doi = {10.1016/s0006-3223(98)00134-6},
	note = {PMID: 9777180},
	langid = {eng}
}

@article{hwang2012,
	title = {Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration},
	author = {Hwang, Rudi and Tiwari, Arun K. and Zai, Clement C. and Felsky, Daniel and Remington, Eli and Wallace, Tessa and Tong, Ryan P. and Souza, Renan P. and Oh, Gabriel and Potkin, Steven G. and Lieberman, Jeffrey A. and Meltzer, Herbert Y. and Kennedy, James L.},
	year = {2012},
	month = {04},
	date = {2012-04-27},
	journal = {Progress in Neuro-Psychopharmacology & Biological Psychiatry},
	pages = {62--75},
	volume = {37},
	number = {1},
	doi = {10.1016/j.pnpbp.2011.11.018},
	note = {PMID: 22203087},
	langid = {eng}
}

@article{xu2018,
	title = {A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia},
	author = {Xu, Feng-ling and Wu, Xue and Zhang, Jing-jing and Wang, Bao-jie and Yao, Jun},
	year = {2018},
	month = {01},
	date = {2018-01},
	journal = {Neuropsychiatric Disease and Treatment},
	pages = {153--164},
	volume = {Volume 14},
	doi = {10.2147/NDT.S156479},
	url = {https://www.dovepress.com/a-meta-analysis-of-data-associating-drd4-gene-polymorphisms-with-schiz-peer-reviewed-article-NDT},
	langid = {en}
}

@article{kulkarni2000,
	title = {Dopamine D4 receptors and development of newer antipsychotic drugs},
	author = {Kulkarni, S. K. and Ninan, I.},
	year = {2000},
	month = {12},
	date = {2000-12},
	journal = {Fundamental & Clinical Pharmacology},
	pages = {529--539},
	volume = {14},
	number = {6},
	doi = {10.1111/j.1472-8206.2000.tb00437.x},
	note = {PMID: 11206702},
	langid = {eng}
}

@article{corrigan2004,
	title = {Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: a placebo-controlled trial},
	author = {Corrigan, Mark H and Gallen, Christopher C and Bonura, M.Luisa and Merchant, Kalpana M},
	year = {2004},
	month = {03},
	date = {2004-03},
	journal = {Biological Psychiatry},
	pages = {445--451},
	volume = {55},
	number = {5},
	doi = {10.1016/j.biopsych.2003.10.004},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S000632230301076X},
	langid = {en}
}

@article{kapur2001,
	title = {Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis},
	author = {Kapur, S. and Seeman, P.},
	year = {2001},
	month = {03},
	date = {2001-03},
	journal = {The American Journal of Psychiatry},
	pages = {360--369},
	volume = {158},
	number = {3},
	doi = {10.1176/appi.ajp.158.3.360},
	note = {PMID: 11229973},
	langid = {eng}
}

@article{seeman2002,
	title = {Atypical antipsychotics: mechanism of action},
	author = {Seeman, Philip},
	year = {2002},
	month = {02},
	date = {2002-02},
	journal = {Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie},
	pages = {27--38},
	volume = {47},
	number = {1},
	note = {PMID: 11873706},
	langid = {eng}
}

@article{zeberg2018,
	title = {Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal side-effects},
	author = {Zeberg, Hugo and Sahlholm, Kristoffer},
	year = {2018},
	month = {12},
	date = {2018-12},
	journal = {Nature Communications},
	pages = {3577},
	volume = {9},
	number = {1},
	doi = {10.1038/s41467-018-04489-x},
	url = {http://www.nature.com/articles/s41467-018-04489-x},
	langid = {en}
}

@article{roth2004,
	title = {Fast dissociation rates predict neither efficacy nor lack of side-effects},
	author = {Roth, Bryan L. and Kroeze, Wesley K. and Sheffler, Douglas J.},
	year = {2004},
	month = {10},
	date = {2004-10},
	journal = {Nature Reviews Drug Discovery},
	pages = {894--894},
	volume = {3},
	number = {10},
	doi = {10.1038/nrd1346-c2},
	url = {http://www.nature.com/articles/nrd1346-c2},
	langid = {en}
}

@article{sahlholm2014,
	title = {Typical and atypical antipsychotics do not differ markedly in their reversibility of antagonism of the dopamine D2 receptor},
	author = {Sahlholm, Kristoffer and Marcellino, Daniel and Nilsson, Johanna and {Ögren}, Sven Ove and Fuxe, Kjell and {Århem}, Peter},
	year = {2014},
	month = {01},
	date = {2014-01},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {149--155},
	volume = {17},
	number = {01},
	doi = {10.1017/S1461145713000801},
	url = {https://academic.oup.com/ijnp/article-lookup/doi/10.1017/S1461145713000801},
	langid = {en}
}

@article{stahl2001,
	title = {Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, {"}Goldilocks{"} actions at dopamine receptors},
	author = {Stahl, S. M.},
	year = {2001},
	month = {11},
	date = {2001-11},
	journal = {The Journal of Clinical Psychiatry},
	pages = {841--842},
	volume = {62},
	number = {11},
	doi = {10.4088/jcp.v62n1101},
	note = {PMID: 11775041},
	langid = {eng}
}

@article{tuplin2017,
	title = {Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity},
	author = {Tuplin, Erin W. and Holahan, Matthew R.},
	year = {2017},
	month = {11},
	date = {2017-11-14},
	journal = {Current Neuropharmacology},
	pages = {1192--1207},
	volume = {15},
	number = {8},
	doi = {10.2174/1570159X15666170413115754},
	note = {PMID: 28412910
PMCID: PMC5725548},
	langid = {eng}
}

@article{möller2014,
	title = {History, background, concepts and current use of comedication and polypharmacy in psychiatry},
	author = {{Möller}, H.-J. and {Seemüller}, F. and Schennach-Wolff, R. and {Stübner}, S. and {Rüther}, E. and Grohmann, R.},
	year = {2014},
	month = {07},
	date = {2014-07},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {983--996},
	volume = {17},
	number = {07},
	doi = {10.1017/S1461145713000837},
	url = {https://academic.oup.com/ijnp/article-lookup/doi/10.1017/S1461145713000837},
	langid = {en}
}

@article{wadworth1990,
	title = {Remoxipride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in schizophrenia},
	author = {Wadworth, A. N. and Heel, R. C.},
	year = {1990},
	month = {12},
	date = {1990-12},
	journal = {Drugs},
	pages = {863--879},
	volume = {40},
	number = {6},
	doi = {10.2165/00003495-199040060-00008},
	note = {PMID: 1981869},
	langid = {eng}
}

@article{schoemaker1997,
	title = {Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity},
	author = {Schoemaker, H. and Claustre, Y. and Fage, D. and Rouquier, L. and Chergui, K. and Curet, O. and Oblin, A. and Gonon, F. and Carter, C. and Benavides, J. and Scatton, B.},
	year = {1997},
	month = {01},
	date = {1997-01},
	journal = {The Journal of Pharmacology and Experimental Therapeutics},
	pages = {83--97},
	volume = {280},
	number = {1},
	note = {PMID: 8996185},
	langid = {eng}
}

@article{köhler1992,
	title = {Regional distribution and in vivo binding of the atypical antipsychotic drug remoxipride. A biochemical and autoradiographic analysis in the rat brain},
	author = {{Köhler}, C. and {Rades ter}, A. C. and Karlsson-Boethius, G. and Bryske, B. and Widman, M.},
	year = {1992},
	month = {02},
	date = {1992-02},
	journal = {Journal of Neural Transmission},
	pages = {49--62},
	volume = {87},
	number = {1},
	doi = {10.1007/BF01253110},
	url = {http://link.springer.com/10.1007/BF01253110},
	langid = {en}
}

@article{möller2003,
	title = {Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality},
	author = {{Möller}, {Hans-Jürgen}},
	year = {2003},
	month = {10},
	date = {2003-10},
	journal = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
	pages = {1101--1111},
	volume = {27},
	number = {7},
	doi = {10.1016/j.pnpbp.2003.09.006},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0278584603002197},
	langid = {en}
}

@article{luptáková2021,
	title = {Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood{\textendash}brain barrier},
	author = {{Luptáková}, Dominika and Vallianatou, Theodosia and Nilsson, Anna and Shariatgorji, Reza and Hammarlund-Udenaes, Margareta and Loryan, Irena and {Andrén}, Per E.},
	year = {2021},
	month = {12},
	date = {2021-12},
	journal = {Molecular Psychiatry},
	pages = {7732--7745},
	volume = {26},
	number = {12},
	doi = {10.1038/s41380-021-01267-y},
	url = {https://www.nature.com/articles/s41380-021-01267-y},
	langid = {en}
}

@article{sekhar2019,
	title = {Region-specific blood{\textendash}brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer{\textquoteright}s disease},
	author = {Sekhar, Gayathri Nair and Fleckney, Alice L. and Boyanova, Sevda Tomova and Rupawala, Huzefa and Lo, Rachel and Wang, Hao and Farag, Doaa B. and Rahman, Khondaker Miraz and Broadstock, Martin and Reeves, Suzanne and Thomas, Sarah Ann},
	year = {2019},
	month = {12},
	date = {2019-12},
	journal = {Fluids and Barriers of the CNS},
	pages = {38},
	volume = {16},
	number = {1},
	doi = {10.1186/s12987-019-0158-1},
	url = {https://fluidsbarrierscns.biomedcentral.com/articles/10.1186/s12987-019-0158-1},
	langid = {en}
}

@article{farah2005,
	title = {Atypicality of atypical antipsychotics},
	author = {Farah, Andrew},
	year = {2005},
	date = {2005},
	journal = {Primary Care Companion to the Journal of Clinical Psychiatry},
	pages = {268--274},
	volume = {7},
	number = {6},
	doi = {10.4088/pcc.v07n0602},
	note = {PMID: 16498489
PMCID: PMC1324958},
	langid = {eng}
}

@article{gründer2009,
	title = {The 'atypicality' of antipsychotics: a concept re-examined and re-defined},
	author = {{Gründer}, Gerhard and Hippius, Hanns and Carlsson, Arvid},
	year = {2009},
	month = {03},
	date = {2009-03},
	journal = {Nature Reviews. Drug Discovery},
	pages = {197--202},
	volume = {8},
	number = {3},
	doi = {10.1038/nrd2806},
	note = {PMID: 19214197},
	langid = {eng}
}

@article{meltzer1989,
	title = {The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs},
	author = {Meltzer, H. Y. and Matsubara, S. and Lee, J. C.},
	year = {1989},
	date = {1989},
	journal = {Psychopharmacology Bulletin},
	pages = {390--392},
	volume = {25},
	number = {3},
	note = {PMID: 2576319},
	langid = {eng}
}

@article{meltzer1999,
	title = {The Role of Serotonin in Antipsychotic Drug Action},
	author = {Meltzer, H},
	year = {1999},
	month = {08},
	date = {1999-08},
	journal = {Neuropsychopharmacology},
	pages = {106S--115S},
	volume = {21},
	number = {2},
	doi = {10.1016/S0893-133X(99)00046-9},
	url = {http://www.nature.com/doifinder/10.1016/S0893-133X(99)00046-9},
	langid = {en}
}

@article{lukasiewicz2010,
	title = {Hetero-dimerization of serotonin 5-HT(2A) and dopamine D(2) receptors},
	author = {Lukasiewicz, Sylwia and Polit, Agnieszka and {K{\k{e}}dracka-Krok}, Sylwia and {W{\k{e}}dzony}, Krzysztof and {Ma{\'{c}}kowiak}, Marzena and Dziedzicka-Wasylewska, Marta},
	year = {2010},
	month = {12},
	date = {2010-12},
	journal = {Biochimica Et Biophysica Acta},
	pages = {1347--1358},
	volume = {1803},
	number = {12},
	doi = {10.1016/j.bbamcr.2010.08.010},
	note = {PMID: 20831885},
	langid = {eng}
}

@article{green1999,
	title = {Should schizophrenia be treated as a neurocognitive disorder?},
	author = {Green, M. F. and Nuechterlein, K. H.},
	year = {1999},
	date = {1999},
	journal = {Schizophrenia Bulletin},
	pages = {309--319},
	volume = {25},
	number = {2},
	doi = {10.1093/oxfordjournals.schbul.a033380},
	note = {PMID: 10416733},
	langid = {eng}
}

@article{bortolozzi2005,
	title = {The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity},
	author = {Bortolozzi, {Analía} and {Díaz-Mataix}, {Llorenç} and Scorza, M. Cecilia and Celada, Pau and Artigas, Francesc},
	year = {2005},
	month = {12},
	date = {2005-12},
	journal = {Journal of Neurochemistry},
	pages = {1597--1607},
	volume = {95},
	number = {6},
	doi = {10.1111/j.1471-4159.2005.03485.x},
	note = {PMID: 16277612},
	langid = {eng}
}

@article{gobert1999,
	title = {Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats},
	author = {Gobert, A. and Millan, M. J.},
	year = {1999},
	month = {02},
	date = {1999-02},
	journal = {Neuropharmacology},
	pages = {315--317},
	volume = {38},
	number = {2},
	doi = {10.1016/s0028-3908(98)00188-9},
	note = {PMID: 10218874},
	langid = {eng}
}

@article{jakab1998,
	title = {5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites},
	author = {Jakab, R. L. and Goldman-Rakic, P. S.},
	year = {1998},
	month = {01},
	date = {1998-01-20},
	journal = {Proceedings of the National Academy of Sciences of the United States of America},
	pages = {735--740},
	volume = {95},
	number = {2},
	doi = {10.1073/pnas.95.2.735},
	note = {PMID: 9435262
PMCID: PMC18490},
	langid = {eng}
}

@article{martin1997,
	title = {The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)},
	author = {Martin, P. and Waters, N. and Carlsson, A. and Carlsson, M. L.},
	year = {1997},
	date = {1997},
	journal = {Journal of Neural Transmission (Vienna, Austria: 1996)},
	pages = {561--564},
	volume = {104},
	number = {4-5},
	doi = {10.1007/BF01277672},
	note = {PMID: 9295186},
	langid = {eng}
}

@article{duinkerke1993,
	title = {Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial},
	author = {Duinkerke, S. J. and Botter, P. A. and Jansen, A. A. and van Dongen, P. A. and van Haaften, A. J. and Boom, A. J. and van Laarhoven, J. H. and Busard, H. L.},
	year = {1993},
	month = {10},
	date = {1993-10},
	journal = {The British Journal of Psychiatry: The Journal of Mental Science},
	pages = {451--455},
	volume = {163},
	doi = {10.1192/bjp.163.4.451},
	note = {PMID: 7902766},
	langid = {eng}
}

@article{akhondzadeh2008,
	title = {Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study},
	author = {Akhondzadeh, Shahin and Malek-Hosseini, Mojgan and Ghoreishi, Aboulfazl and Raznahan, Maedeh and Rezazadeh, Shams-Ali},
	year = {2008},
	month = {12},
	date = {2008-12-12},
	journal = {Progress in Neuro-Psychopharmacology & Biological Psychiatry},
	pages = {1879--1883},
	volume = {32},
	number = {8},
	doi = {10.1016/j.pnpbp.2008.08.020},
	note = {PMID: 18801405},
	langid = {eng}
}

@article{ebdrup2011,
	title = {Serotonin 2A receptor antagonists for treatment of schizophrenia},
	author = {Ebdrup, {Bjørn H} and Rasmussen, Hans and Arnt, {Jørn} and {Glenthøj}, Birte},
	year = {2011},
	month = {09},
	date = {2011-09},
	journal = {Expert Opinion on Investigational Drugs},
	pages = {1211--1223},
	volume = {20},
	number = {9},
	doi = {10.1517/13543784.2011.601738},
	url = {http://www.tandfonline.com/doi/full/10.1517/13543784.2011.601738},
	langid = {en}
}

@article{olivier2001,
	title = {The 5-HT(1A) receptor knockout mouse and anxiety},
	author = {Olivier, B. and Pattij, T. and Wood, S. J. and Oosting, R. and Sarnyai, Z. and Toth, M.},
	year = {2001},
	month = {11},
	date = {2001-11},
	journal = {Behavioural Pharmacology},
	pages = {439--450},
	volume = {12},
	number = {6-7},
	doi = {10.1097/00008877-200111000-00004},
	note = {PMID: 11742137},
	langid = {eng}
}

@article{nash2008,
	title = {Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study},
	author = {Nash, Jon R. and Sargent, Peter A. and Rabiner, Eugenii A. and Hood, Sean D. and Argyropoulos, Spilios V. and Potokar, John P. and Grasby, Paul M. and Nutt, David J.},
	year = {2008},
	month = {09},
	date = {2008-09},
	journal = {The British Journal of Psychiatry: The Journal of Mental Science},
	pages = {229--234},
	volume = {193},
	number = {3},
	doi = {10.1192/bjp.bp.107.041186},
	note = {PMID: 18757983},
	langid = {eng}
}

@article{dawson2009,
	title = {Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders},
	author = {Dawson, Lee A. and Watson, Jeannette M.},
	year = {2009},
	date = {2009},
	journal = {CNS neuroscience & therapeutics},
	pages = {107--117},
	volume = {15},
	number = {2},
	doi = {10.1111/j.1755-5949.2008.00067.x},
	note = {PMID: 19499624
PMCID: PMC6493994},
	langid = {eng}
}

@article{fitzjohn2010,
	title = {A study of long-term potentiation in transgenic mice over-expressing mutant forms of both amyloid precursor protein and presenilin-1},
	author = {Fitzjohn, Stephen M and Kuenzi, Frederick and Morton, Robin A and Rosahl, Thomas W and Lewis, Huw and Smith, David and Seabrook, Guy R and Collingridge, Graham L},
	year = {2010},
	date = {2010},
	journal = {Molecular Brain},
	pages = {21},
	volume = {3},
	number = {1},
	doi = {10.1186/1756-6606-3-21},
	url = {http://molecularbrain.biomedcentral.com/articles/10.1186/1756-6606-3-21},
	langid = {en}
}

@article{jordan2002,
	title = {The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor},
	author = {Jordan, Shaun and Koprivica, Vuk and Chen, Ruoyan and Tottori, Katsura and Kikuchi, Tetsuro and Altar, C. Anthony},
	year = {2002},
	month = {04},
	date = {2002-04-26},
	journal = {European Journal of Pharmacology},
	pages = {137--140},
	volume = {441},
	number = {3},
	doi = {10.1016/s0014-2999(02)01532-7},
	note = {PMID: 12063084},
	langid = {eng}
}

@article{newmantancredi2011,
	title = {Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties},
	author = {Newman-Tancredi, Adrian and Kleven, Mark S.},
	year = {2011},
	month = {08},
	date = {2011-08},
	journal = {Psychopharmacology},
	pages = {451--473},
	volume = {216},
	number = {4},
	doi = {10.1007/s00213-011-2247-y},
	note = {PMID: 21394633},
	langid = {eng}
}

@article{ye2014,
	title = {Dual ligands targeting dopamine D2 and serotonin 5-HT1A receptors as new antipsychotical or anti-Parkinsonian agents},
	author = {Ye, Na and Song, Zilan and Zhang, Ao},
	year = {2014},
	date = {2014},
	journal = {Current Medicinal Chemistry},
	pages = {437--457},
	volume = {21},
	number = {4},
	doi = {10.2174/09298673113206660300},
	note = {PMID: 24164194},
	langid = {eng}
}

@article{kishi2013,
	title = {Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trials},
	author = {Kishi, Taro and Iwata, Nakao},
	year = {2013},
	month = {09},
	date = {2013-09},
	journal = {CNS drugs},
	pages = {731--741},
	volume = {27},
	number = {9},
	doi = {10.1007/s40263-013-0085-7},
	note = {PMID: 23812802},
	langid = {eng}
}

@article{kane2015,
	title = {Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial},
	author = {Kane, John M. and Zukin, Stephen and Wang, Yao and Lu, Kaifeng and Ruth, Adam and Nagy, {Krisztián} and Laszlovszky, {István} and Durgam, Suresh},
	year = {2015},
	month = {08},
	date = {2015-08},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {367--373},
	volume = {35},
	number = {4},
	doi = {10.1097/JCP.0000000000000346},
	url = {https://journals.lww.com/00004714-201508000-00003},
	langid = {en}
}


@article{citrome_cariprazine_2016,
	title = {Cariprazine for the {Treatment} of {Schizophrenia}: {A} {Review} of this {Dopamine} {D3}-{Preferring} {D3}/{D2} {Receptor} {Partial} {Agonist}},
	volume = {10},
	issn = {1935-1232},
	shorttitle = {Cariprazine for the {Treatment} of {Schizophrenia}},
	doi = {10.3371/1935-1232-10.2.109},
	language = {eng},
	number = {2},
	journal = {Clinical Schizophrenia \& Related Psychoses},
	author = {Citrome, Leslie},
	year = {2016},
	pmid = {27440212},
	keywords = {Antipsychotic Agents, Humans, Schizophrenia, Treatment Outcome, Depressive Disorder, Major, Bipolar Disorder, Piperazines, Psychopharmacology, Dopamine, Receptors, Dopamine D2, Receptors, Dopamine D3, Dopamine Agonists, Antipsychotic, Cariprazine, Drug Partial Agonism},
	pages = {109--119},
}

@article{ghaleiha2010,
	title = {A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia},
	author = {Ghaleiha, Ali and Noorbala, Ahmad Ali and Farnaghi, Farhad and Hajiazim, Mohammad and Akhondzadeh, Shahin},
	year = {2010},
	month = {12},
	date = {2010-12},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {678--682},
	volume = {30},
	number = {6},
	doi = {10.1097/jcp.0b013e3181fa8720},
	note = {PMID: 21105281},
	langid = {eng}
}

@article{wang2019,
	title = {Co-treatment of buspirone with atypical antipsychotic drugs (AAPDs) improved neurocognitive function in chronic schizophrenia},
	author = {Wang, Yu and Yang, Xiao and Song, Xiuli and Zhao, Liansheng and Wei, Jinxue and Wang, Jixiang and Tian, Hong and Zheng, Congyu and Wei, Min and Wang, Qiang and Guo, Wanjun and Deng, Wei and Li, Tao and Ma, Xiaohong},
	year = {2019},
	month = {07},
	date = {2019-07},
	journal = {Schizophrenia Research},
	pages = {135--140},
	volume = {209},
	doi = {10.1016/j.schres.2019.05.006},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0920996419301677},
	langid = {en}
}

@article{temmingh2015,
	title = {Anxiety in Patients with Schizophrenia: Epidemiology and Management},
	author = {Temmingh, Henk and Stein, Dan J.},
	year = {2015},
	date = {2015},
	journal = {CNS drugs},
	pages = {819--832},
	volume = {29},
	number = {10},
	doi = {10.1007/s40263-015-0282-7},
	note = {PMID: 26482261},
	langid = {eng}
}

@article{fayyaz2008,
	title = {Serotonin receptor modulators in the treatment of irritable bowel syndrome},
	author = {Fayyaz, Mohammad and Lackner, Jeffrey M.},
	year = {2008},
	month = {02},
	date = {2008-02},
	journal = {Therapeutics and Clinical Risk Management},
	pages = {41--48},
	volume = {4},
	number = {1},
	doi = {10.2147/tcrm.s140},
	note = {PMID: 18728719
PMCID: PMC2503665},
	langid = {eng}
}

@article{wang1994,
	title = {The role of 5-HT3-like receptors in the action of clozapine},
	author = {Wang, R. Y. and Ashby, C. R. and Edwards, E. and Zhang, J. Y.},
	year = {1994},
	month = {09},
	date = {1994-09},
	journal = {The Journal of Clinical Psychiatry},
	pages = {23--26},
	volume = {55 Suppl B},
	note = {PMID: 7961566},
	langid = {eng}
}

@article{sirota2000,
	title = {Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia},
	author = {Sirota, P. and Mosheva, T. and Shabtay, H. and Giladi, N. and Korczyn, A. D.},
	year = {2000},
	month = {02},
	date = {2000-02},
	journal = {The American Journal of Psychiatry},
	pages = {287--289},
	volume = {157},
	number = {2},
	doi = {10.1176/appi.ajp.157.2.287},
	note = {PMID: 10671405},
	langid = {eng}
}


@article{kishi_selective_2014,
	title = {Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review},
	volume = {16},
	issn = {1559-1174},
	shorttitle = {Selective serotonin 3 receptor antagonist treatment for schizophrenia},
	doi = {10.1007/s12017-013-8251-0},
	language = {eng},
	number = {1},
	journal = {Neuromolecular Medicine},
	author = {Kishi, Taro and Mukai, Tomohiko and Matsuda, Yuki and Iwata, Nakao},
	month = mar,
	year = {2014},
	pmid = {23896722},
	keywords = {Antipsychotic Agents, Constipation, Double-Blind Method, Drug Therapy, Combination, Granisetron, Haloperidol, Humans, Indoles, Nausea, Ondansetron, Randomized Controlled Trials as Topic, Receptors, Serotonin, 5-HT3, Risperidone, Schizophrenia, Serotonin 5-HT3 Receptor Antagonists, Severity of Illness Index, Symptom Assessment, Treatment Outcome, Tropisetron, Vomiting},
	pages = {61--69},
}

@article{khodaieardakani2013,
	title = {Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study},
	author = {Khodaie-Ardakani, Mohammad-Reza and Seddighi, Sahar and Modabbernia, Amirhossein and Rezaei, Farzin and Salehi, Bahman and Ashrafi, Mandana and Shams-Alizadeh, Narges and Mohammad-Karimi, Maryam and Esfandiari, Gholam-Reza and Hajiaghaee, Reza and Akhondzadeh, Shahin},
	year = {2013},
	month = {04},
	date = {2013-04},
	journal = {Journal of Psychiatric Research},
	pages = {472--478},
	volume = {47},
	number = {4},
	doi = {10.1016/j.jpsychires.2013.01.011},
	note = {PMID: 23375406},
	langid = {eng}
}

@article{hashimoto2005,
	title = {Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of alpha 7 nicotinic acetylcholine receptors},
	author = {Hashimoto, Kenji and Iyo, Masaomi and Freedman, Robert and Stevens, Karen E.},
	year = {2005},
	month = {11},
	date = {2005-11},
	journal = {Psychopharmacology},
	pages = {13--19},
	volume = {183},
	number = {1},
	doi = {10.1007/s00213-005-0142-0},
	note = {PMID: 16136299},
	langid = {eng}
}

@article{yamamoto2004,
	title = {Proposal for a noradrenaline hypothesis of schizophrenia},
	author = {Yamamoto, Kenichi and Hornykiewicz, Oleh},
	year = {2004},
	month = {08},
	date = {2004-08},
	journal = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
	pages = {913--922},
	volume = {28},
	number = {5},
	doi = {10.1016/j.pnpbp.2004.05.033},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0278584604000910},
	langid = {en}
}

@article{mazeh2004,
	title = {Venlafaxine for the treatment of depressive episode during the course of schizophrenia},
	author = {Mazeh, Doron and Shahal, Baruch and Saraf, Roni and Melamed, Yuval},
	year = {2004},
	month = {12},
	date = {2004-12},
	journal = {Journal of Clinical Psychopharmacology},
	pages = {653--655},
	volume = {24},
	number = {6},
	doi = {10.1097/01.jcp.0000144894.37611.0a},
	note = {PMID: 15538129},
	langid = {eng}
}

@article{svensson2003,
	title = {Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality},
	author = {Svensson, Torgny H.},
	year = {2003},
	month = {10},
	date = {2003-10},
	journal = {Progress in Neuro-Psychopharmacology & Biological Psychiatry},
	pages = {1145--1158},
	volume = {27},
	number = {7},
	doi = {10.1016/j.pnpbp.2003.09.009},
	note = {PMID: 14642973},
	langid = {eng}
}

@article{baldessarini1992,
	title = {Do central antiadrenergic actions contribute to the atypical properties of clozapine?},
	author = {Baldessarini, R. J. and Huston-Lyons, D. and Campbell, A. and Marsh, E. and Cohen, B. M.},
	year = {1992},
	month = {05},
	date = {1992-05},
	journal = {The British Journal of Psychiatry. Supplement},
	pages = {12--16},
	number = {17},
	note = {PMID: 1418884},
	langid = {eng}
}

@article{brosda2014,
	title = {α2-Adrenoceptors are targets for antipsychotic drugs},
	author = {Brosda, Jan and Jantschak, Florian and Pertz, Heinz H.},
	year = {2014},
	month = {03},
	date = {2014-03},
	journal = {Psychopharmacology},
	pages = {801--812},
	volume = {231},
	number = {5},
	doi = {10.1007/s00213-014-3459-8},
	note = {PMID: 24488407},
	langid = {eng}
}

@article{hasselmo1992,
	title = {Cholinergic modulation of cortical associative memory function},
	author = {Hasselmo, M. E. and Anderson, B. P. and Bower, J. M.},
	year = {1992},
	month = {05},
	date = {1992-05-01},
	journal = {Journal of Neurophysiology},
	pages = {1230--1246},
	volume = {67},
	number = {5},
	doi = {10.1152/jn.1992.67.5.1230},
	url = {https://www.physiology.org/doi/10.1152/jn.1992.67.5.1230},
	langid = {en}
}

@article{levey1996,
	title = {Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease},
	author = {Levey, {Allan{\hspace{0.167em}}I.}},
	year = {1996},
	month = {11},
	date = {1996-11-26},
	journal = {Proceedings of the National Academy of Sciences},
	pages = {13541--13546},
	volume = {93},
	number = {24},
	doi = {10.1073/pnas.93.24.13541},
	url = {https://pnas.org/doi/full/10.1073/pnas.93.24.13541},
	langid = {en}
}

@article{picciotto2002,
	title = {Nicotinic receptors in aging and dementia},
	author = {Picciotto, Marina R. and Zoli, Michele},
	year = {2002},
	month = {12},
	date = {2002-12},
	journal = {Journal of Neurobiology},
	pages = {641--655},
	volume = {53},
	number = {4},
	doi = {10.1002/neu.10102},
	url = {https://onlinelibrary.wiley.com/doi/10.1002/neu.10102},
	langid = {en}
}

@article{hoskin2019,
	title = {Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer{\textquoteright}s Dementia: An Update},
	author = {Hoskin, Justin L and Al-Hasan, Yazan and Sabbagh, Marwan Noel},
	year = {2019},
	month = {02},
	date = {2019-02-18},
	journal = {Nicotine & Tobacco Research},
	pages = {370--376},
	volume = {21},
	number = {3},
	doi = {10.1093/ntr/nty116},
	url = {https://academic.oup.com/ntr/article/21/3/370/5078079},
	langid = {en}
}

@article{raedler2007,
	title = {Towards a muscarinic hypothesis of schizophrenia},
	author = {Raedler, T J and Bymaster, F P and Tandon, R and Copolov, D and Dean, B},
	year = {2007},
	month = {03},
	date = {2007-03-01},
	journal = {Molecular Psychiatry},
	pages = {232--246},
	volume = {12},
	number = {3},
	doi = {10.1038/sj.mp.4001924},
	url = {https://www.nature.com/articles/4001924},
	langid = {en}
}

@article{singh1987,
	title = {Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtyping},
	author = {Singh, M. M. and Kay, S. R. and Opler, L. A.},
	year = {1987},
	month = {02},
	date = {1987-02},
	journal = {Psychological Medicine},
	pages = {39--48},
	volume = {17},
	number = {1},
	doi = {10.1017/s0033291700012964},
	note = {PMID: 3575576},
	langid = {eng}
}

@article{tandon1992,
	title = {Effect of anticholinergics on positive and negative symptoms in schizophrenia},
	author = {Tandon, R. and DeQuardo, J. R. and Goodson, J. and Mann, N. A. and Greden, J. F.},
	year = {1992},
	date = {1992},
	journal = {Psychopharmacology Bulletin},
	pages = {297--302},
	volume = {28},
	number = {3},
	note = {PMID: 1480733},
	langid = {eng}
}

@article{zemishlany1996,
	title = {Trihexyphenidyl (Artane) abuse in schizophrenic patients},
	author = {Zemishlany, Z. and Aizenberg, D. and Weiner, Z. and Weizman, A.},
	year = {1996},
	month = {09},
	date = {1996-09},
	journal = {International Clinical Psychopharmacology},
	pages = {199--202},
	volume = {11},
	number = {3},
	doi = {10.1097/00004850-199609000-00007},
	note = {PMID: 8923099},
	langid = {eng}
}

@article{yeomans1995,
	title = {Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia},
	author = {Yeomans, J. S.},
	year = {1995},
	month = {02},
	date = {1995-02},
	journal = {Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology},
	pages = {3--16},
	volume = {12},
	number = {1},
	doi = {10.1038/sj.npp.1380235},
	note = {PMID: 7766284},
	langid = {eng}
}

@article{scarr2007,
	title = {Altered Hippocampal Muscarinic M4, but Not M1, Receptor Expression from Subjects with Schizophrenia},
	author = {Scarr, Elizabeth and Sundram, Suresh and Keriakous, Dahlia and Dean, Brian},
	year = {2007},
	month = {05},
	date = {2007-05},
	journal = {Biological Psychiatry},
	pages = {1161--1170},
	volume = {61},
	number = {10},
	doi = {10.1016/j.biopsych.2006.08.050},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0006322306011619},
	langid = {en}
}

@article{gibbons2013,
	title = {Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia},
	author = {Gibbons, Andrew Stuart and Scarr, Elizabeth and Boer, Simone and Money, Tammie and Jeon, Won-Je and Felder, Chris and Dean, Brian},
	year = {2013},
	month = {02},
	date = {2013-02},
	journal = {The International Journal of Neuropsychopharmacology},
	pages = {37--46},
	volume = {16},
	number = {1},
	doi = {10.1017/S1461145712000028},
	note = {PMID: 22338582},
	langid = {eng}
}

@article{friedman2004,
	title = {Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists},
	author = {Friedman, JosephI.},
	year = {2004},
	month = {06},
	date = {2004-06},
	journal = {Psychopharmacology},
	volume = {174},
	number = {1},
	doi = {10.1007/s00213-004-1794-x},
	url = {http://link.springer.com/10.1007/s00213-004-1794-x},
	langid = {en}
}

@article{sur2003,
	title = {N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity},
	author = {Sur, Cyrille and Mallorga, Pierre J. and Wittmann, Marion and Jacobson, Marlene A. and Pascarella, Danette and Williams, Jacinta B. and Brandish, Philip E. and Pettibone, Douglas J. and Scolnick, Edward M. and Conn, P. Jeffrey},
	year = {2003},
	month = {11},
	date = {2003-11-11},
	journal = {Proceedings of the National Academy of Sciences of the United States of America},
	pages = {13674--13679},
	volume = {100},
	number = {23},
	doi = {10.1073/pnas.1835612100},
	note = {PMID: 14595031
PMCID: PMC263872},
	langid = {eng}
}

@article{yohn2018,
	title = {Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia},
	author = {Yohn, Samantha E. and Conn, P. Jeffrey},
	year = {2018},
	month = {07},
	date = {2018-07-01},
	journal = {Neuropharmacology},
	pages = {438--448},
	volume = {136},
	number = {Pt C},
	doi = {10.1016/j.neuropharm.2017.09.012},
	note = {PMID: 28893562
PMCID: PMC5844786},
	langid = {eng}
}

@article{foster2021,
	title = {Targeting muscarinic receptors to treat schizophrenia},
	author = {Foster, Daniel J. and Bryant, Zoey K. and Conn, P. Jeffrey},
	year = {2021},
	month = {05},
	date = {2021-05-07},
	journal = {Behavioural Brain Research},
	pages = {113201},
	volume = {405},
	doi = {10.1016/j.bbr.2021.113201},
	note = {PMID: 33647377
PMCID: PMC8006961},
	langid = {eng}
}

@article{kim2007,
	title = {Antipsychotic drug-induced weight gain mediated by histamine H {\textsubscript{1}} receptor-linked activation of hypothalamic AMP-kinase},
	author = {Kim, Sangwon F. and Huang, Alex S. and Snowman, Adele M. and Teuscher, Cory and Snyder, Solomon H.},
	year = {2007},
	month = {02},
	date = {2007-02-27},
	journal = {Proceedings of the National Academy of Sciences},
	pages = {3456--3459},
	volume = {104},
	number = {9},
	doi = {10.1073/pnas.0611417104},
	url = {https://pnas.org/doi/full/10.1073/pnas.0611417104},
	langid = {en}
}

@article{kola2008,
	title = {Role of AMP-activated protein kinase in the control of appetite},
	author = {Kola, B.},
	year = {2008},
	month = {07},
	date = {2008-07},
	journal = {Journal of Neuroendocrinology},
	pages = {942--951},
	volume = {20},
	number = {7},
	doi = {10.1111/j.1365-2826.2008.01745.x},
	note = {PMID: 18445126
PMCID: PMC2658714},
	langid = {eng}
}

@article{lópez2016,
	title = {Hypothalamic AMPK: a canonical regulator of whole-body energy balance},
	author = {{López}, Miguel and Nogueiras, {Rubén} and Tena-Sempere, Manuel and {Diéguez}, Carlos},
	year = {2016},
	month = {07},
	date = {2016-07},
	journal = {Nature Reviews Endocrinology},
	pages = {421--432},
	volume = {12},
	number = {7},
	doi = {10.1038/nrendo.2016.67},
	url = {http://www.nature.com/articles/nrendo.2016.67},
	langid = {en}
}

@article{vohora2012,
	title = {Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuse},
	author = {Vohora, Divya and Bhowmik, Malay},
	year = {2012},
	date = {2012},
	journal = {Frontiers in Systems Neuroscience},
	volume = {6},
	doi = {10.3389/fnsys.2012.00072},
	url = {http://journal.frontiersin.org/article/10.3389/fnsys.2012.00072/abstract}
}

@article{cheng2021,
	title = {The Histaminergic System in Neuropsychiatric Disorders},
	author = {Cheng, Li and Liu, Jiaying and Chen, Zhong},
	year = {2021},
	month = {09},
	date = {2021-09-11},
	journal = {Biomolecules},
	pages = {1345},
	volume = {11},
	number = {9},
	doi = {10.3390/biom11091345},
	url = {https://www.mdpi.com/2218-273X/11/9/1345},
	langid = {en}
}

@article{skoog1986,
	title = {Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine},
	author = {Skoog, K. M. and Cain, S. T. and Nemeroff, C. B.},
	year = {1986},
	month = {07},
	date = {1986-07},
	journal = {Neuropharmacology},
	pages = {777--782},
	volume = {25},
	number = {7},
	doi = {10.1016/0028-3908(86)90095-x},
	note = {PMID: 3748325},
	langid = {eng}
}

@article{holly2011,
	title = {The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats},
	author = {Holly, Elizabeth N. and Ebrecht, Bree and Prus, Adam J.},
	year = {2011},
	month = {07},
	date = {2011-07},
	journal = {European Neuropsychopharmacology},
	pages = {526--531},
	volume = {21},
	number = {7},
	doi = {10.1016/j.euroneuro.2010.12.004},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0924977X10002804},
	langid = {en}
}

@article{binder2001,
	title = {The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs},
	author = {Binder, E. B. and Kinkead, B. and Owens, M. J. and Nemeroff, C. B.},
	year = {2001},
	month = {12},
	date = {2001-12-01},
	journal = {Biological Psychiatry},
	pages = {856--872},
	volume = {50},
	number = {11},
	doi = {10.1016/s0006-3223(01)01211-2},
	note = {PMID: 11743941},
	langid = {eng}
}

@article{palacios1981,
	title = {Neurotensin receptors are located on dopamine-containing neurones in rat midbrain},
	author = {Palacios, J. M. and Kuhar, M. J.},
	year = {1981},
	month = {12},
	date = {1981-12-10},
	journal = {Nature},
	pages = {587--589},
	volume = {294},
	number = {5841},
	doi = {10.1038/294587a0},
	note = {PMID: 6273751},
	langid = {eng}
}

@article{hershenberg2014,
	title = {Role of atypical antipsychotics in the treatment of generalized anxiety disorder},
	author = {Hershenberg, Rachel and Gros, Daniel F. and Brawman-Mintzer, Olga},
	year = {2014},
	month = {06},
	date = {2014-06},
	journal = {CNS drugs},
	pages = {519--533},
	volume = {28},
	number = {6},
	doi = {10.1007/s40263-014-0162-6},
	note = {PMID: 24794100},
	langid = {eng}
}

@article{kinkead2002,
	title = {Neurotensin: an endogenous antipsychotic?},
	author = {Kinkead, Becky and Nemeroff, Charles B.},
	year = {2002},
	month = {02},
	date = {2002-02},
	journal = {Current Opinion in Pharmacology},
	pages = {99--103},
	volume = {2},
	number = {1},
	doi = {10.1016/s1471-4892(01)00128-x},
	note = {PMID: 11786316},
	langid = {eng}
}

@article{boules2013,
	title = {Diverse Roles of Neurotensin Agonists in the Central Nervous System},
	author = {Boules, Mona and Li, Zhimin and Smith, Kristin and Fredrickson, Paul and Richelson, Elliott},
	year = {2013},
	date = {2013},
	journal = {Frontiers in Endocrinology},
	volume = {4},
	doi = {10.3389/fendo.2013.00036},
	url = {http://journal.frontiersin.org/article/10.3389/fendo.2013.00036/abstract}
}

@article{lacrosse2013,
	title = {Neuropeptide systems and schizophrenia},
	author = {LaCrosse, Amber L. and Olive, M. Foster},
	year = {2013},
	month = {08},
	date = {2013-08},
	journal = {CNS & neurological disorders drug targets},
	pages = {619--632},
	volume = {12},
	number = {5},
	doi = {10.2174/1871527311312050010},
	note = {PMID: 23574175},
	langid = {eng}
}

@article{moroji1982,
	title = {Antipsychotic Effects of Ceruletide (Caerulein) on Chronic Schizophrenia},
	author = {Moroji, Takashi},
	year = {1982},
	month = {04},
	date = {1982-04-01},
	journal = {Archives of General Psychiatry},
	pages = {485},
	volume = {39},
	number = {4},
	doi = {10.1001/archpsyc.1982.04290040079011},
	url = {http://archpsyc.jamanetwork.com/article.aspx?doi=10.1001/archpsyc.1982.04290040079011},
	langid = {en}
}

@article{mattes1985,
	title = {Ceruletide for schizophrenia: a double-blind study},
	author = {Mattes, J. A. and Hom, W. and Rochford, J. M. and Orlosky, M.},
	year = {1985},
	month = {05},
	date = {1985-05},
	journal = {Biological Psychiatry},
	pages = {533--538},
	volume = {20},
	number = {5},
	doi = {10.1016/0006-3223(85)90024-1},
	note = {PMID: 2859054},
	langid = {eng}
}

@article{lindström1985,
	title = {CSF-Neuropeptides in schizophrenia},
	author = {{Lindström}, Leif H.},
	year = {1985},
	month = {01},
	date = {1985-01},
	journal = {Nordisk Psykiatrisk Tidsskrift},
	pages = {51--55},
	volume = {39},
	number = {sup11},
	doi = {10.3109/08039488509101957},
	url = {http://www.tandfonline.com/doi/full/10.3109/08039488509101957},
	langid = {en}
}

@article{peters1990,
	title = {Neuropeptide Y-like immunoreactivity in schizophrenia},
	author = {Peters, Jeffrey and Van Kammen, Daniel P. and Gelernter, Joel and Yao, Jeffrey and Shaw, David},
	year = {1990},
	month = {10},
	date = {1990-10},
	journal = {Schizophrenia Research},
	pages = {287--294},
	volume = {3},
	number = {5-6},
	doi = {10.1016/0920-9964(90)90012-V},
	url = {https://linkinghub.elsevier.com/retrieve/pii/092099649090012V},
	langid = {en}
}

@article{berrettini1987,
	title = {Cerebrospinal fluid neuropeptide Y in depression and schizophrenia},
	author = {Berrettini, W. H. and Doran, A. R. and Kelsoe, J. and Roy, A. and Pickar, D.},
	year = {1987},
	month = {12},
	date = {1987-12},
	journal = {Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology},
	pages = {81--83},
	volume = {1},
	number = {1},
	doi = {10.1016/0893-133x(87)90013-3},
	note = {PMID: 3509070},
	langid = {eng}
}

@article{moralesmedina2010,
	title = {A possible role of neuropeptide Y in depression and stress},
	author = {Morales-Medina, {Julio César} and Dumont, Yvan and Quirion, {Rémi}},
	year = {2010},
	month = {02},
	date = {2010-02},
	journal = {Brain Research},
	pages = {194--205},
	volume = {1314},
	doi = {10.1016/j.brainres.2009.09.077},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S000689930902037X},
	langid = {en}
}

@article{zambello2010,
	title = {Chronic psychosocial stress alters NPY system: different effects in rat and tree shrew},
	author = {Zambello, E. and Fuchs, E. and Abumaria, N. and Rygula, R. and Domenici, E. and Caberlotto, L.},
	year = {2010},
	month = {02},
	date = {2010-02-01},
	journal = {Progress in Neuro-Psychopharmacology & Biological Psychiatry},
	pages = {122--130},
	volume = {34},
	number = {1},
	doi = {10.1016/j.pnpbp.2009.10.011},
	note = {PMID: 19846047},
	langid = {eng}
}

@article{sharma2022,
	title = {Effect of depression and suicidal behavior on neuropeptide Y (NPY) and its receptors in the adult human brain: A postmortem study},
	author = {Sharma, Anuradha and Ren, Xinguo and Zhang, Hui and Pandey, Ghanshyam N.},
	year = {2022},
	month = {01},
	date = {2022-01},
	journal = {Progress in Neuro-Psychopharmacology and Biological Psychiatry},
	pages = {110428},
	volume = {112},
	doi = {10.1016/j.pnpbp.2021.110428},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0278584621001871},
	langid = {en}
}

@article{mickey2011,
	title = {Emotion processing, major depression, and functional genetic variation of neuropeptide Y},
	author = {Mickey, Brian J. and Zhou, Zhifeng and Heitzeg, Mary M. and Heinz, Elizabeth and Hodgkinson, Colin A. and Hsu, David T. and Langenecker, Scott A. and Love, Tiffany M. and {Peciña}, Marta and Shafir, Tal and Stohler, Christian S. and Goldman, David and Zubieta, Jon-Kar},
	year = {2011},
	month = {02},
	date = {2011-02},
	journal = {Archives of General Psychiatry},
	pages = {158--166},
	volume = {68},
	number = {2},
	doi = {10.1001/archgenpsychiatry.2010.197},
	note = {PMID: 21300944
PMCID: PMC3091621},
	langid = {eng}
}

@article{mathé2020,
	title = {A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder},
	author = {{Mathé}, Aleksander A and Michaneck, Miranda and Berg, Elisabeth and Charney, Dennis S and Murrough, James W},
	year = {2020},
	month = {12},
	date = {2020-12-29},
	journal = {International Journal of Neuropsychopharmacology},
	pages = {783--790},
	volume = {23},
	number = {12},
	doi = {10.1093/ijnp/pyaa054},
	url = {https://academic.oup.com/ijnp/article/23/12/783/5917572},
	langid = {en}
}

@article{nahvi2021,
	title = {Intranasal Neuropeptide Y as a Potential Therapeutic for Depressive Behavior in the Rodent Single Prolonged Stress Model in Females},
	author = {Nahvi, Roxanna J. and Tanelian, Arax and Nwokafor, Chiso and Hollander, Callie M. and Peacock, Lauren and Sabban, Esther L.},
	year = {2021},
	month = {09},
	date = {2021-09-08},
	journal = {Frontiers in Behavioral Neuroscience},
	pages = {705579},
	volume = {15},
	doi = {10.3389/fnbeh.2021.705579},
	url = {https://www.frontiersin.org/articles/10.3389/fnbeh.2021.705579/full}
}

@article{obuchowicz2004,
	title = {Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?},
	author = {Obuchowicz, E and Krysiak, R and Herman, Z},
	year = {2004},
	month = {10},
	date = {2004-10},
	journal = {Neuroscience & Biobehavioral Reviews},
	pages = {595--610},
	volume = {28},
	number = {6},
	doi = {10.1016/j.neubiorev.2004.08.006},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0149763404000867},
	langid = {en}
}

@article{kirk2006,
	title = {Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus},
	author = {Kirk, Shona L. and Cahir, Marie and Reynolds, Gavin P.},
	year = {2006},
	month = {07},
	date = {2006-07},
	journal = {Journal of Psychopharmacology},
	pages = {577--579},
	volume = {20},
	number = {4},
	doi = {10.1177/0269881106061199},
	url = {http://journals.sagepub.com/doi/10.1177/0269881106061199},
	langid = {en}
}

@article{yuen2021,
	title = {A Focused Review of the Metabolic Side-Effects of Clozapine},
	author = {Yuen, Jessica W. Y. and Kim, David D. and Procyshyn, Ric M. and Panenka, William J. and Honer, William G. and Barr, Alasdair M.},
	year = {2021},
	month = {02},
	date = {2021-02-25},
	journal = {Frontiers in Endocrinology},
	pages = {609240},
	volume = {12},
	doi = {10.3389/fendo.2021.609240},
	url = {https://www.frontiersin.org/articles/10.3389/fendo.2021.609240/full}
}

@article{marsh2021,
	title = {Oxytocin and the Neurobiology of Prosocial Behavior},
	author = {Marsh, Nina and Marsh, Abigail A. and Lee, Mary R. and Hurlemann, {René}},
	year = {2021},
	month = {12},
	date = {2021-12},
	journal = {The Neuroscientist},
	pages = {604--619},
	volume = {27},
	number = {6},
	doi = {10.1177/1073858420960111},
	url = {http://journals.sagepub.com/doi/10.1177/1073858420960111},
	langid = {en}
}

@article{javed2018,
	title = {The Importance of Social Cognition in Improving Functional Outcomes in Schizophrenia},
	author = {Javed, Afzal and Charles, Asha},
	year = {2018},
	month = {04},
	date = {2018-04-24},
	journal = {Frontiers in Psychiatry},
	pages = {157},
	volume = {9},
	doi = {10.3389/fpsyt.2018.00157},
	url = {http://journal.frontiersin.org/article/10.3389/fpsyt.2018.00157/full}
}

@article{bell2017,
	title = {Rethinking Social Cognition in Light of Psychosis: Reciprocal Implications for Cognition and Psychopathology},
	author = {Bell, Vaughan and Mills, Kathryn L. and Modinos, Gemma and Wilkinson, Sam},
	year = {2017},
	month = {05},
	date = {2017-05},
	journal = {Clinical Psychological Science: A Journal of the Association for Psychological Science},
	pages = {537--550},
	volume = {5},
	number = {3},
	doi = {10.1177/2167702616677079},
	note = {PMID: 28533946
PMCID: PMC5437982},
	langid = {eng}
}

@article{caldwell2009,
	title = {Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice},
	author = {Caldwell, H. K. and Stephens, S. L. and Young, W. S.},
	year = {2009},
	month = {02},
	date = {2009-02},
	journal = {Molecular Psychiatry},
	pages = {190--196},
	volume = {14},
	number = {2},
	doi = {10.1038/sj.mp.4002150},
	note = {PMID: 18227836},
	langid = {eng}
}

@article{feifel1999,
	title = {Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating},
	author = {Feifel, D. and Reza, T.},
	year = {1999},
	month = {01},
	date = {1999-01},
	journal = {Psychopharmacology},
	pages = {93--98},
	volume = {141},
	number = {1},
	doi = {10.1007/s002130050811},
	note = {PMID: 9952070},
	langid = {eng}
}

@article{lee2005,
	title = {Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin},
	author = {Lee, Paul R. and Brady, Dana L. and Shapiro, Robert A. and Dorsa, Daniel M. and Koenig, James I.},
	year = {2005},
	month = {10},
	date = {2005-10},
	journal = {Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology},
	pages = {1883--1894},
	volume = {30},
	number = {10},
	doi = {10.1038/sj.npp.1300722},
	note = {PMID: 15798779},
	langid = {eng}
}

@article{smith2010,
	title = {Manipulation of the oxytocin system alters social behavior and attraction in pair-bonding primates, Callithrix penicillata},
	author = {Smith, Adam S. and Agmo, Anders and Birnie, Andrew K. and French, Jeffrey A.},
	year = {2010},
	month = {02},
	date = {2010-02},
	journal = {Hormones and Behavior},
	pages = {255--262},
	volume = {57},
	number = {2},
	doi = {10.1016/j.yhbeh.2009.12.004},
	note = {PMID: 20025881
PMCID: PMC2824532},
	langid = {eng}
}

@article{peñagarikano2015,
	title = {Exogenous and evoked oxytocin restores social behavior in the {\emph{Cntnap2}} mouse model of autism},
	author = {{Peñagarikano}, Olga and {Lázaro}, {María T.} and Lu, Xiao-Hong and Gordon, Aaron and Dong, Hongmei and Lam, Hoa A. and Peles, Elior and Maidment, Nigel T. and Murphy, Niall P. and Yang, X. William and Golshani, Peyman and Geschwind, Daniel H.},
	year = {2015},
	month = {01},
	date = {2015-01-21},
	journal = {Science Translational Medicine},
	volume = {7},
	number = {271},
	doi = {10.1126/scitranslmed.3010257},
	url = {https://www.science.org/doi/10.1126/scitranslmed.3010257},
	langid = {en}
}

@article{bujanow1974,
	title = {Letter: Is oxytocin an anti-schizophrenic hormone?},
	author = {Bujanow, W.},
	year = {1974},
	month = {06},
	date = {1974-06},
	journal = {Canadian Psychiatric Association Journal},
	pages = {323},
	volume = {19},
	number = {3},
	doi = {10.1177/070674377401900323},
	note = {PMID: 4841051},
	langid = {eng}
}

@article{pedersen2011,
	title = {Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia},
	author = {Pedersen, Cort A. and Gibson, Clare M. and Rau, Shane W. and Salimi, Kayvon and Smedley, Kelly L. and Casey, Robin L. and Leserman, Jane and Jarskog, L. Fredrik and Penn, David L.},
	year = {2011},
	month = {10},
	date = {2011-10},
	journal = {Schizophrenia Research},
	pages = {50--53},
	volume = {132},
	number = {1},
	doi = {10.1016/j.schres.2011.07.027},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0920996411004257},
	langid = {en}
}

@article{davis2013,
	title = {Effects of single dose intranasal oxytocin on social cognition in schizophrenia},
	author = {Davis, Michael C. and Lee, Junghee and Horan, William P. and Clarke, Angelika D. and McGee, Mark R. and Green, Michael F. and Marder, Stephen R.},
	year = {2013},
	month = {07},
	date = {2013-07},
	journal = {Schizophrenia Research},
	pages = {393--397},
	volume = {147},
	number = {2-3},
	doi = {10.1016/j.schres.2013.04.023},
	note = {PMID: 23676253},
	langid = {eng}
}

@article{guastella2015,
	title = {A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia},
	author = {Guastella, Adam J. and Ward, Philip B. and Hickie, Ian B. and Shahrestani, Sara and Hodge, Marie Antoinette Redoblado and Scott, Elizabeth M. and Langdon, Robyn},
	year = {2015},
	month = {11},
	date = {2015-11},
	journal = {Schizophrenia Research},
	pages = {628--633},
	volume = {168},
	number = {3},
	doi = {10.1016/j.schres.2015.06.005},
	note = {PMID: 26150070},
	langid = {eng}
}

@article{goh2021,
	title = {Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment},
	author = {Goh, Kah Kheng and Chen, Chun-Hsin and Lane, Hsien-Yuan},
	year = {2021},
	month = {02},
	date = {2021-02-21},
	journal = {International Journal of Molecular Sciences},
	pages = {2146},
	volume = {22},
	number = {4},
	doi = {10.3390/ijms22042146},
	url = {https://www.mdpi.com/1422-0067/22/4/2146},
	langid = {en}
}


@article{zheng_adjunctive_2019,
	title = {Adjunctive intranasal oxytocin for schizophrenia: {A} meta-analysis of randomized, double-blind, placebo-controlled trials},
	volume = {206},
	issn = {09209964},
	shorttitle = {Adjunctive intranasal oxytocin for schizophrenia},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0920996418306959},
	doi = {10.1016/j.schres.2018.12.007},
	language = {en},
	urldate = {2022-05-09},
	journal = {Schizophrenia Research},
	author = {Zheng, Wei and Zhu, Xiao-Min and Zhang, Qing-E and Yang, Xin-Hu and Cai, Dong-Bin and Li, Lu and Li, Xian-Bin and Ng, Chee H. and Ungvari, Gabor S. and Ning, Yu-Ping and Xiang, Yu-Tao},
	month = apr,
	year = {2019},
	pages = {13--20},
}

@article{saavedravelez2009,
	title = {Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review},
	author = {Saavedra-Velez, Carlos and Yusim, Anna and Anbarasan, Deepti and Lindenmayer, Jean-Pierre},
	year = {2009},
	month = {01},
	date = {2009-01},
	journal = {The Journal of Clinical Psychiatry},
	pages = {104--112},
	volume = {70},
	number = {1},
	doi = {10.4088/jcp.07r03982},
	note = {PMID: 19026265},
	langid = {eng}
}

@article{teitelman2001,
	title = {Modafinil for narcolepsy},
	author = {Teitelman, E.},
	year = {2001},
	month = {06},
	date = {2001-06},
	journal = {The American Journal of Psychiatry},
	pages = {970--971},
	volume = {158},
	number = {6},
	doi = {10.1176/appi.ajp.158.6.970-a},
	note = {PMID: 11384922},
	langid = {eng}
}

@article{rosenthal2004,
	title = {Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia},
	author = {Rosenthal, Murray H. and Bryant, Sharon L.},
	year = {2004},
	month = {02},
	date = {2004-02},
	journal = {Clinical Neuropharmacology},
	pages = {38--43},
	volume = {27},
	number = {1},
	doi = {10.1097/00002826-200401000-00011},
	note = {PMID: 15090936},
	langid = {eng}
}

@article{hunter2006,
	title = {Impact of modafinil on prefrontal executive function in schizophrenia},
	author = {Hunter, Michael D. and Ganesan, Venkatasubramanian and Wilkinson, Iain D. and Spence, Sean A.},
	year = {2006},
	month = {12},
	date = {2006-12},
	journal = {The American Journal of Psychiatry},
	pages = {2184--2186},
	volume = {163},
	number = {12},
	doi = {10.1176/appi.ajp.163.12.2184},
	note = {PMID: 17151173},
	langid = {eng}
}

@article{turner2004,
	title = {Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia},
	author = {Turner, Danielle C. and Clark, Luke and Pomarol-Clotet, Edith and McKenna, Peter and Robbins, Trevor W. and Sahakian, Barbara J.},
	year = {2004},
	month = {07},
	date = {2004-07},
	journal = {Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology},
	pages = {1363--1373},
	volume = {29},
	number = {7},
	doi = {10.1038/sj.npp.1300457},
	note = {PMID: 15085092},
	langid = {eng}
}

@article{siegel2001,
	title = {A Brief History of Hypocretin/Orexin and Narcolepsy},
	author = {Siegel, J},
	year = {2001},
	month = {11},
	date = {2001-11},
	journal = {Neuropsychopharmacology},
	pages = {S14--S20},
	volume = {25},
	number = {5},
	doi = {10.1016/S0893-133X(01)00317-7},
	url = {http://www.nature.com/doifinder/10.1016/S0893-133X(01)00317-7}
}

@article{deutch2006,
	title = {The Orexins/Hypocretins and Schizophrenia},
	author = {Deutch, A. Y. and Bubser, M.},
	year = {2006},
	month = {10},
	date = {2006-10-27},
	journal = {Schizophrenia Bulletin},
	pages = {1277--1283},
	volume = {33},
	number = {6},
	doi = {10.1093/schbul/sbm096},
	url = {https://academic.oup.com/schizophreniabulletin/article-lookup/doi/10.1093/schbul/sbm096},
	langid = {en}
}

@article{misiak2019,
	title = {Appetite regulating hormones in first-episode psychosis: A systematic review and meta-analysis},
	author = {Misiak, {B{\l}a{\.{z}}ej} and Bartoli, Francesco and Stramecki, Filip and Samochowiec, Jerzy and Lis, {Micha{\l}} and Kasznia, Justyna and Jarosz, Konrad and {Sta{\'{n}}czykiewicz}, {Bart{\l}omiej}},
	year = {2019},
	month = {07},
	date = {2019-07},
	journal = {Neuroscience and Biobehavioral Reviews},
	pages = {362--370},
	volume = {102},
	doi = {10.1016/j.neubiorev.2019.05.018},
	note = {PMID: 31121198},
	langid = {eng}
}

@article{lu2021,
	title = {Changes of Hypocretin (Orexin) System in Schizophrenia: From Plasma to Brain},
	author = {Lu, Jing and Huang, Man-Li and Li, Jin-Hui and Jin, Kang-Yu and Li, Hai-Mei and Mou, Ting-Ting and Fronczek, Rolf and Duan, Jin-Feng and Xu, Wei-Juan and Swaab, Dick and Bao, Ai-Min},
	year = {2021},
	month = {08},
	date = {2021-08-21},
	journal = {Schizophrenia Bulletin},
	pages = {1310--1319},
	volume = {47},
	number = {5},
	doi = {10.1093/schbul/sbab042},
	url = {https://academic.oup.com/schizophreniabulletin/article/47/5/1310/6273505},
	langid = {en}
}

@article{lambe2007,
	title = {Schizophrenia, hypocretin (orexin), and the thalamocortical activating system},
	author = {Lambe, Evelyn K. and Liu, Rong-Jian and Aghajanian, George K.},
	year = {2007},
	month = {11},
	date = {2007-11},
	journal = {Schizophrenia Bulletin},
	pages = {1284--1290},
	volume = {33},
	number = {6},
	doi = {10.1093/schbul/sbm088},
	note = {PMID: 17656637
PMCID: PMC2779889},
	langid = {eng}
}

@article{li2020,
	title = {Orexin A alleviates neuroinflammation via OXR2/CaMKKβ/AMPK signaling pathway after ICH in mice},
	author = {Li, Tao and Xu, Weilin and Ouyang, Jinsong and Lu, Xiaoyang and Sherchan, Prativa and Lenahan, Cameron and Irio, Giselle and Zhang, John H. and Zhao, Jianhua and Zhang, Yongfa and Tang, Jiping},
	year = {2020},
	month = {06},
	date = {2020-06-15},
	journal = {Journal of Neuroinflammation},
	pages = {187},
	volume = {17},
	number = {1},
	doi = {10.1186/s12974-020-01841-1},
	note = {PMID: 32539736
PMCID: PMC7294616},
	langid = {eng}
}

@article{couvineau2019,
	title = {Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases},
	author = {Couvineau, Alain and Voisin, Thierry and Nicole, Pascal and Gratio, {Valérie} and Abad, Catalina and Tan, Yossan-Var},
	year = {2019},
	date = {2019},
	journal = {Frontiers in Endocrinology},
	pages = {709},
	volume = {10},
	doi = {10.3389/fendo.2019.00709},
	note = {PMID: 31695678
PMCID: PMC6817618},
	langid = {eng}
}

@article{bickerton1961,
	title = {Evidence for a Central Mechanism in Angiotensin Induced Hypertension.},
	author = {Bickerton, R. K. and Buckley, J. P.},
	year = {1961},
	month = {04},
	date = {1961-04-01},
	journal = {Experimental Biology and Medicine},
	pages = {834--836},
	volume = {106},
	number = {4},
	doi = {10.3181/00379727-106-26492},
	url = {http://ebm.sagepub.com/lookup/doi/10.3181/00379727-106-26492},
	langid = {en}
}

@article{ganten1971,
	title = {Angiotensin-forming enzyme in brain tissue},
	author = {Ganten, D. and Minnich, J. L. and Granger, P. and Hayduk, K. and Brecht, H. M. and Barbeau, A. and Boucher, R. and Genest, J.},
	year = {1971},
	month = {07},
	date = {1971-07-02},
	journal = {Science (New York, N.Y.)},
	pages = {64--65},
	volume = {173},
	number = {3991},
	doi = {10.1126/science.173.3991.64},
	note = {PMID: 4325865},
	langid = {eng}
}

@article{allen2006,
	title = {Expression of constitutively active angiotensin receptors in the rostral ventrolateral medulla increases blood pressure},
	author = {Allen, Andrew M. and Dosanjh, Jaspreet K. and Erac, Marco and Dassanayake, Sashikala and Hannan, Ross D. and Thomas, Walter G.},
	year = {2006},
	month = {06},
	date = {2006-06},
	journal = {Hypertension (Dallas, Tex.: 1979)},
	pages = {1054--1061},
	volume = {47},
	number = {6},
	doi = {10.1161/01.HYP.0000218576.36574.54},
	note = {PMID: 16618838},
	langid = {eng}
}

@article{lee-kirsch1999,
	title = {Distinct renin isoforms generated by tissue-specific transcription initiation and alternative splicing},
	author = {Lee-Kirsch, M. A. and Gaudet, F. and Cardoso, M. C. and Lindpaintner, K.},
	year = {1999},
	month = {02},
	date = {1999-02-05},
	journal = {Circulation Research},
	pages = {240--246},
	volume = {84},
	number = {2},
	doi = {10.1161/01.res.84.2.240},
	note = {PMID: 9933256},
	langid = {eng}
}

@article{grobe2008,
	title = {An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy},
	author = {Grobe, Justin L. and Xu, Di and Sigmund, Curt D.},
	year = {2008},
	month = {08},
	date = {2008-08},
	journal = {Physiology (Bethesda, Md.)},
	pages = {187--193},
	volume = {23},
	doi = {10.1152/physiol.00002.2008},
	note = {PMID: 18697992
PMCID: PMC2538674},
	langid = {eng}
}

@article{jackson2018,
	title = {Within the Brain: The Renin Angiotensin System},
	author = {Jackson, LaDonya and Eldahshan, Wael and Fagan, Susan C. and Ergul, Adviye},
	year = {2018},
	month = {03},
	date = {2018-03-15},
	journal = {International Journal of Molecular Sciences},
	pages = {E876},
	volume = {19},
	number = {3},
	doi = {10.3390/ijms19030876},
	note = {PMID: 29543776
PMCID: PMC5877737},
	langid = {eng}
}

@article{guimond2012,
	title = {How does angiotensin AT2 receptor activation help neuronal differentiation and improve neuronal pathological situations?},
	author = {Guimond, Marie-Odile and Gallo-Payet, Nicole},
	year = {2012},
	date = {2012},
	journal = {Frontiers in Endocrinology},
	volume = {3},
	doi = {10.3389/fendo.2012.00164},
	url = {http://journal.frontiersin.org/article/10.3389/fendo.2012.00164/abstract}
}

@article{raasch2006,
	title = {Angiotensin II Inhibition Reduces Stress Sensitivity of Hypothalamo-Pituitary-Adrenal Axis in Spontaneously Hypertensive Rats},
	author = {Raasch, Walter and Wittmershaus, Christian and Dendorfer, Andreas and Voges, Inga and Pahlke, Friedrich and Dodt, Christoph and Dominiak, Peter and {Jöhren}, Olaf},
	year = {2006},
	month = {07},
	date = {2006-07-01},
	journal = {Endocrinology},
	pages = {3539--3546},
	volume = {147},
	number = {7},
	doi = {10.1210/en.2006-0198},
	url = {https://academic.oup.com/endo/article/147/7/3539/2501303},
	langid = {en}
}

@article{yang1996,
	title = {Angiotensin II- An Important Stress Hormone},
	author = {Yang, Gang and Wan, Yu and Zhu, Yilian},
	year = {1996},
	date = {1996},
	journal = {Neurosignals},
	pages = {1--8},
	volume = {5},
	number = {1},
	doi = {10.1159/000109168},
	url = {https://www.karger.com/Article/FullText/109168},
	langid = {en}
}

@article{cosarderelioglu2020,
	title = {Brain Renin{\textendash}Angiotensin System at the Intersect of Physical and Cognitive Frailty},
	author = {Cosarderelioglu, Caglar and Nidadavolu, Lolita S. and George, Claudene J. and Oh, Esther S. and Bennett, David A. and Walston, Jeremy D. and Abadir, Peter M.},
	year = {2020},
	month = {09},
	date = {2020-09-30},
	journal = {Frontiers in Neuroscience},
	pages = {586314},
	volume = {14},
	doi = {10.3389/fnins.2020.586314},
	url = {https://www.frontiersin.org/article/10.3389/fnins.2020.586314/full}
}

@article{royea2020,
	title = {AT2R{\textquoteright}s (Angiotensin II Type 2 Receptor{\textquoteright}s) Role in Cognitive and Cerebrovascular Deficits in a Mouse Model of Alzheimer Disease},
	author = {Royea, Jessika and Lacalle-Aurioles, Maria and Trigiani, Lianne J and Fermigier, Alice and Hamel, Edith},
	year = {2020},
	month = {06},
	date = {2020-06},
	journal = {Hypertension},
	pages = {1464--1474},
	volume = {75},
	number = {6},
	doi = {10.1161/HYPERTENSIONAHA.119.14431},
	url = {https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.119.14431},
	langid = {en}
}

@article{oh2019,
	title = {The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy},
	author = {Oh, SeungJu Jackie and Fan, Xiaoduo},
	year = {2019},
	month = {06},
	date = {2019-06},
	journal = {CNS drugs},
	pages = {539--547},
	volume = {33},
	number = {6},
	doi = {10.1007/s40263-019-00632-4},
	note = {PMID: 30993607},
	langid = {eng}
}

@article{fan2017,
	title = {The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia},
	author = {Fan, X. and Song, X. and Zhao, M. and Jarskog, L. F. and Natarajan, R. and Shukair, N. and Freudenreich, O. and Henderson, D. C. and Goff, D. C.},
	year = {2017},
	month = {11},
	date = {2017-11},
	journal = {Acta Psychiatrica Scandinavica},
	pages = {465--472},
	volume = {136},
	number = {5},
	doi = {10.1111/acps.12799},
	note = {PMID: 28851055
PMCID: PMC5630515},
	langid = {eng}
}

@article{wahlbeck1993,
	title = {Elevated angiotensin-converting enzyme (kininase II) in the cerebrospinal fluid of neuroleptic-treated schizophrenic patients},
	author = {Wahlbeck, Kristian and {Rimón}, Ranan and Fyhrquist, Frej},
	year = {1993},
	month = {03},
	date = {1993-03},
	journal = {Schizophrenia Research},
	pages = {77--82},
	volume = {9},
	number = {1},
	doi = {10.1016/0920-9964(93)90013-9},
	url = {https://linkinghub.elsevier.com/retrieve/pii/0920996493900139},
	langid = {en}
}

@article{shinkai2003,
	title = {Genetic approaches to polydipsia in schizophrenia: a preliminary report of a family study and an association study of an angiotensin-converting enzyme gene polymorphism},
	author = {Shinkai, Takahiro and Ohmori, Osamu and Hori, Hiroko and Nakamura, Jun},
	year = {2003},
	month = {05},
	date = {2003-05-15},
	journal = {American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics},
	pages = {7--12},
	volume = {119B},
	number = {1},
	doi = {10.1002/ajmg.b.10066},
	note = {PMID: 12707930},
	langid = {eng}
}

@article{chauquet2021,
	title = {Association of Antihypertensive Drug Target Genes With Psychiatric Disorders: A Mendelian Randomization Study},
	author = {Chauquet, Solal and Zhu, Zhihong and {O'Donovan}, Michael C. and Walters, James T. R. and Wray, Naomi R. and Shah, Sonia},
	year = {2021},
	month = {06},
	date = {2021-06-01},
	journal = {JAMA psychiatry},
	pages = {623--631},
	volume = {78},
	number = {6},
	doi = {10.1001/jamapsychiatry.2021.0005},
	note = {PMID: 33688928
PMCID: PMC7948097},
	langid = {eng}
}

@article{miller2019,
	title = {Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology},
	author = {Miller, Brian J. and Goldsmith, David R.},
	year = {2019},
	month = {12},
	date = {2019-12},
	journal = {Biomarkers in Neuropsychiatry},
	pages = {100006},
	volume = {1},
	doi = {10.1016/j.bionps.2019.100006},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S2666144619300061},
	langid = {en}
}

@article{panariello2020,
	title = {How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis},
	author = {Panariello, Fabio and Cellini, Lorenzo and Speciani, Maurizio and De Ronchi, Diana and Atti, Anna Rita},
	year = {2020},
	month = {11},
	date = {2020-11-16},
	journal = {Frontiers in Psychiatry},
	pages = {582345},
	volume = {11},
	doi = {10.3389/fpsyt.2020.582345},
	url = {https://www.frontiersin.org/articles/10.3389/fpsyt.2020.582345/full}
}

@article{martin1976,
	title = {The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog},
	author = {Martin, W. R. and Eades, C. G. and Thompson, J. A. and Huppler, R. E. and Gilbert, P. E.},
	year = {1976},
	month = {06},
	date = {1976-06},
	journal = {The Journal of Pharmacology and Experimental Therapeutics},
	pages = {517--532},
	volume = {197},
	number = {3},
	note = {PMID: 945347},
	langid = {eng}
}

@article{hayashi2005,
	title = {The sigma receptor: evolution of the concept in neuropsychopharmacology},
	author = {Hayashi, T. and Su, Tp},
	year = {2005},
	month = {10},
	date = {2005-10},
	journal = {Current Neuropharmacology},
	pages = {267--280},
	volume = {3},
	number = {4},
	doi = {10.2174/157015905774322516},
	note = {PMID: 18369400
PMCID: PMC2268997},
	langid = {eng}
}

@article{tam1984,
	title = {Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes},
	author = {Tam, S. W. and Cook, L.},
	year = {1984},
	month = {09},
	date = {1984-09},
	journal = {Proceedings of the National Academy of Sciences of the United States of America},
	pages = {5618--5621},
	volume = {81},
	number = {17},
	doi = {10.1073/pnas.81.17.5618},
	note = {PMID: 6147851
PMCID: PMC391758},
	langid = {eng}
}

@article{hayashi2004,
	title = {Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders},
	author = {Hayashi, Teruo and Su, Tsung-Ping},
	year = {2004},
	date = {2004},
	journal = {CNS drugs},
	pages = {269--284},
	volume = {18},
	number = {5},
	doi = {10.2165/00023210-200418050-00001},
	note = {PMID: 15089113},
	langid = {eng}
}

@article{largent1988,
	title = {Novel antipsychotic drugs share high affinity for sigma receptors},
	author = {Largent, B. L. and {Wikström}, H. and Snowman, A. M. and Snyder, S. H.},
	year = {1988},
	month = {10},
	date = {1988-10-18},
	journal = {European Journal of Pharmacology},
	pages = {345--347},
	volume = {155},
	number = {3},
	doi = {10.1016/0014-2999(88)90527-4},
	note = {PMID: 2906878},
	langid = {eng}
}

@article{gilmore2004,
	title = {Review of the pharmacological and clinical profile of rimcazole},
	author = {Gilmore, Deborah L. and Liu, Yun and Matsumoto, Rae R.},
	year = {2004},
	date = {2004},
	journal = {CNS drug reviews},
	pages = {1--22},
	volume = {10},
	number = {1},
	doi = {10.1111/j.1527-3458.2004.tb00001.x},
	note = {PMID: 14978511
PMCID: PMC6741722},
	langid = {eng}
}

@article{gewirtz1994,
	title = {BMY 14802, a Sigma Receptor Ligand for the Treatment of Schizophrenia},
	author = {Gewirtz, George R. and Gorman, Jack M. and Volavka, Jan and Macaluso, Joseph and Gribkoff, Greta and Taylor, Duncan P. and Borison, Richard},
	year = {1994},
	month = {02},
	date = {1994-02},
	journal = {Neuropsychopharmacology},
	pages = {37--40},
	volume = {10},
	number = {1},
	doi = {10.1038/npp.1994.5},
	url = {http://www.nature.com/articles/npp19945},
	langid = {en}
}

@article{modell1996,
	title = {Efficacy and safety of an opiate sigma-receptor antagonist (SL 82.0715) in schizophrenic patients with negative symptoms: an open dose-range study},
	author = {Modell, S. and Naber, D. and Holzbach, R.},
	year = {1996},
	month = {03},
	date = {1996-03},
	journal = {Pharmacopsychiatry},
	pages = {63--66},
	volume = {29},
	number = {2},
	doi = {10.1055/s-2007-979546},
	note = {PMID: 8741023},
	langid = {eng}
}

@article{huber1999,
	title = {Efficacy and safety of the sigma receptor ligand EMD 57445 (panamesine) in patients with schizophrenia: an open clinical trial},
	author = {Huber, M. T. and Gotthardt, U. and Schreiber, W. and Krieg, J. C.},
	year = {1999},
	month = {03},
	date = {1999-03},
	journal = {Pharmacopsychiatry},
	pages = {68--72},
	volume = {32},
	number = {2},
	doi = {10.1055/s-2007-979194},
	note = {PMID: 10333165},
	langid = {eng}
}

@article{weng2017,
	title = {Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases},
	author = {Weng, Tzu-Yu and Tsai, Shang-Yi Anne and Su, Tsung-Ping},
	year = {2017},
	month = {12},
	date = {2017-12},
	journal = {Journal of Biomedical Science},
	pages = {74},
	volume = {24},
	number = {1},
	doi = {10.1186/s12929-017-0380-6},
	url = {http://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-017-0380-6},
	langid = {en}
}

@article{hashimoto2015,
	title = {Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication},
	author = {Hashimoto, Kenji},
	year = {2015},
	month = {01},
	date = {2015-01},
	journal = {Journal of Pharmacological Sciences},
	pages = {6--9},
	volume = {127},
	number = {1},
	doi = {10.1016/j.jphs.2014.11.010},
	note = {PMID: 25704012},
	langid = {eng}
}

@article{albayrak2013,
	title = {Benefical effects of sigma-1 agonist fluvoxamine for tardive dyskinesia and tardive akathisia in patients with schizophrenia: report of three cases},
	author = {Albayrak, Yakup and Hashimoto, Kenji},
	year = {2013},
	month = {12},
	date = {2013-12},
	journal = {Psychiatry Investigation},
	pages = {417--420},
	volume = {10},
	number = {4},
	doi = {10.4306/pi.2013.10.4.417},
	note = {PMID: 24474992
PMCID: PMC3902161},
	langid = {eng}
}

@article{farber2003,
	title = {The NMDA receptor hypofunction model of psychosis},
	author = {Farber, Nuri B.},
	year = {2003},
	month = {11},
	date = {2003-11},
	journal = {Annals of the New York Academy of Sciences},
	pages = {119--130},
	volume = {1003},
	doi = {10.1196/annals.1300.008},
	note = {PMID: 14684440},
	langid = {eng}
}

@article{plitman2014,
	title = {Glutamate-mediated excitotoxicity in schizophrenia: a review},
	author = {Plitman, Eric and Nakajima, Shinichiro and de la Fuente-Sandoval, Camilo and Gerretsen, Philip and Chakravarty, M. Mallar and Kobylianskii, Jane and Chung, Jun Ku and Caravaggio, Fernando and Iwata, Yusuke and Remington, Gary and Graff-Guerrero, Ariel},
	year = {2014},
	month = {10},
	date = {2014-10},
	journal = {European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology},
	pages = {1591--1605},
	volume = {24},
	number = {10},
	doi = {10.1016/j.euroneuro.2014.07.015},
	note = {PMID: 25159198
PMCID: PMC4470624},
	langid = {eng}
}

@article{moghaddam2012,
	title = {From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment},
	author = {Moghaddam, Bita and Javitt, Daniel},
	year = {2012},
	month = {01},
	date = {2012-01},
	journal = {Neuropsychopharmacology},
	pages = {4--15},
	volume = {37},
	number = {1},
	doi = {10.1038/npp.2011.181},
	url = {http://www.nature.com/articles/npp2011181},
	langid = {en}
}

@article{bagasrawala2016,
	title = {N-Methyl D-Aspartate Receptor Antagonist Kynurenic Acid Affects Human Cortical Development},
	author = {Bagasrawala, Inseyah and Zecevic, Nada and {Radonji{\'{c}}}, Nevena V.},
	year = {2016},
	date = {2016},
	journal = {Frontiers in Neuroscience},
	pages = {435},
	volume = {10},
	doi = {10.3389/fnins.2016.00435},
	note = {PMID: 27746712
PMCID: PMC5043058},
	langid = {eng}
}

@article{javitt2005,
	title = {Inhibition of System A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action},
	author = {Javitt, D C and Duncan, L and Balla, A and Sershen, H},
	year = {2005},
	month = {03},
	date = {2005-03-01},
	journal = {Molecular Psychiatry},
	pages = {275--287},
	volume = {10},
	number = {3},
	doi = {10.1038/sj.mp.4001552},
	url = {https://www.nature.com/articles/4001552},
	langid = {en}
}

@article{chang2020,
	title = {Efficacy and cognitive effect of sarcosine (N-methylglycine) in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials},
	author = {Chang, Chun-Hung and Lin, Chieh-Hsin and Liu, Chieh-Yu and Chen, Shaw-Ji and Lane, Hsien-Yuan},
	year = {2020},
	month = {05},
	date = {2020-05},
	journal = {Journal of Psychopharmacology (Oxford, England)},
	pages = {495--505},
	volume = {34},
	number = {5},
	doi = {10.1177/0269881120908016},
	note = {PMID: 32122256},
	langid = {eng}
}

@article{moretto2018,
	title = {Glutamatergic synapses in neurodevelopmental disorders},
	author = {Moretto, Edoardo and Murru, Luca and Martano, Giuseppe and Sassone, Jenny and Passafaro, Maria},
	year = {2018},
	month = {06},
	date = {2018-06-08},
	journal = {Progress in Neuro-Psychopharmacology & Biological Psychiatry},
	pages = {328--342},
	volume = {84},
	number = {Pt B},
	doi = {10.1016/j.pnpbp.2017.09.014},
	note = {PMID: 28935587},
	langid = {eng}
}

@article{egerton2020,
	title = {Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development},
	author = {Egerton, Alice and Grace, Anthony A. and Stone, James and Bossong, Matthijs G. and Sand, Michael and McGuire, Philip},
	year = {2020},
	month = {09},
	date = {2020-09},
	journal = {Schizophrenia Research},
	pages = {59--70},
	volume = {223},
	doi = {10.1016/j.schres.2020.09.013},
	note = {PMID: 33071070},
	langid = {eng}
}

@article{saini2017,
	title = {Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk},
	author = {Saini, S M and Mancuso, S G and Mostaid, Md S and Liu, C and Pantelis, C and Everall, I P and Bousman, C A},
	year = {2017},
	month = {08},
	date = {2017-08},
	journal = {Translational Psychiatry},
	pages = {e1196--e1196},
	volume = {7},
	number = {8},
	doi = {10.1038/tp.2017.172},
	url = {http://www.nature.com/articles/tp2017172},
	langid = {en}
}

@article{poltavskaya2021,
	title = {Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms},
	author = {Poltavskaya, Evgeniya G. and Fedorenko, Olga Yu. and Kornetova, Elena G. and Loonen, Anton J. M. and Kornetov, Alexander N. and Bokhan, Nikolay A. and Ivanova, Svetlana A.},
	year = {2021},
	month = {09},
	date = {2021-09-22},
	journal = {Life},
	pages = {997},
	volume = {11},
	number = {10},
	doi = {10.3390/life11100997},
	url = {https://www.mdpi.com/2075-1729/11/10/997},
	langid = {en}
}

@article{taylor2016,
	title = {Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine},
	author = {Taylor, Danielle L. and Tiwari, Arun K. and Lieberman, Jeffrey A. and Potkin, Steven G. and Meltzer, Herbert Y. and Knight, Jo and Remington, Gary and {Müller}, Daniel J. and Kennedy, James L.},
	year = {2016},
	month = {03},
	date = {2016-03},
	journal = {Human Psychopharmacology},
	pages = {121--134},
	volume = {31},
	number = {2},
	doi = {10.1002/hup.2519},
	note = {PMID: 26876050},
	langid = {eng}
}

@article{lally2016,
	title = {Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics},
	author = {Lally, John and Gaughran, Fiona and Timms, Philip and Curran, Sarah},
	year = {2016},
	month = {11},
	date = {2016-11},
	journal = {Pharmacogenomics and Personalized Medicine},
	pages = {117--129},
	volume = {Volume 9},
	doi = {10.2147/PGPM.S115741},
	url = {https://www.dovepress.com/treatment-resistant-schizophrenia-current-insights-on-the-pharmacogeno-peer-reviewed-article-PGPM},
	langid = {en}
}

@article{hashimoto2011,
	title = {Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia},
	author = {Hashimoto, Kenji and r, },
	year = {2011},
	month = {01},
	date = {2011-01-01},
	journal = {Current Pharmaceutical Design},
	pages = {112--120},
	volume = {17},
	number = {2},
	doi = {10.2174/138161211795049598},
	url = {http://openurl.ingenta.com/content/xref?genre=article&issn=1381-6128&volume=17&issue=2&spage=112},
	langid = {en}
}

@article{roberts2010,
	title = {Glycine transporter inhibition reverses ketamine-induced working memory deficits},
	author = {Roberts, Brooke M. and Shaffer, Christopher L. and Seymour, Patricia A. and Schmidt, Christopher J. and Williams, Graham V. and Castner, Stacy A.},
	year = {2010},
	month = {03},
	date = {2010-03-31},
	journal = {NeuroReport},
	pages = {390--394},
	volume = {21},
	number = {5},
	doi = {10.1097/WNR.0b013e3283381a4e},
	url = {https://journals.lww.com/00001756-201003310-00015},
	langid = {en}
}

@article{pei2021,
	title = {Directly and Indirectly Targeting the Glycine Modulatory Site to Modulate NMDA Receptor Function to Address Unmet Medical Needs of Patients With Schizophrenia},
	author = {Pei, Ju-Chun and Luo, Da-Zhong and Gau, Shiang-Shin and Chang, Chia-Yuan and Lai, Wen-Sung},
	year = {2021},
	month = {10},
	date = {2021-10-01},
	journal = {Frontiers in Psychiatry},
	pages = {742058},
	volume = {12},
	doi = {10.3389/fpsyt.2021.742058},
	url = {https://www.frontiersin.org/articles/10.3389/fpsyt.2021.742058/full}
}

@article{iwata2015,
	title = {Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials},
	author = {Iwata, Y and Nakajima, S and Suzuki, T and Keefe, R S E and Plitman, E and Chung, J K and Caravaggio, F and Mimura, M and Graff-Guerrero, A and Uchida, H},
	year = {2015},
	month = {10},
	date = {2015-10},
	journal = {Molecular Psychiatry},
	pages = {1151--1160},
	volume = {20},
	number = {10},
	doi = {10.1038/mp.2015.68},
	url = {https://www.nature.com/articles/mp201568},
	langid = {en}
}

@article{lin2018,
	title = {Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, Added to Clozapine for the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial},
	author = {Lin, Chieh-Hsin and Lin, Ching-Hua and Chang, Yue-Cune and Huang, Yu-Jhen and Chen, Po-Wei and Yang, Hui-Ting and Lane, Hsien-Yuan},
	year = {2018},
	month = {09},
	date = {2018-09},
	journal = {Biological Psychiatry},
	pages = {422--432},
	volume = {84},
	number = {6},
	doi = {10.1016/j.biopsych.2017.12.006},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S0006322317322977},
	langid = {en}
}

@article{szilágyi2018,
	title = {Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies},
	author = {{Szilágyi}, Bence and Ferenczy, {György G.} and {Keser{{\H u}}}, {György M.}},
	year = {2018},
	month = {10},
	date = {2018-10-03},
	journal = {Expert Opinion on Drug Discovery},
	pages = {973--982},
	volume = {13},
	number = {10},
	doi = {10.1080/17460441.2018.1524459},
	url = {https://www.tandfonline.com/doi/full/10.1080/17460441.2018.1524459},
	langid = {en}
}

@article{jacob2019,
	title = {Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors},
	author = {Jacob, Tija C.},
	year = {2019},
	date = {2019},
	journal = {Frontiers in Molecular Neuroscience},
	pages = {179},
	volume = {12},
	doi = {10.3389/fnmol.2019.00179},
	note = {PMID: 31396049
PMCID: PMC6668551},
	langid = {eng}
}

@article{gill2011,
	title = {A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia},
	author = {Gill, Kathryn M. and Lodge, Daniel J. and Cook, James M. and Aras, Shamim and Grace, Anthony A.},
	year = {2011},
	month = {08},
	date = {2011-08},
	journal = {Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology},
	pages = {1903--1911},
	volume = {36},
	number = {9},
	doi = {10.1038/npp.2011.76},
	note = {PMID: 21562483
PMCID: PMC3154109},
	langid = {eng}
}

@article{seeman1975,
	title = {Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons},
	author = {Seeman, P. and Lee, T.},
	year = {1975},
	month = {06},
	date = {1975-06-20},
	journal = {Science},
	pages = {1217--1219},
	volume = {188},
	number = {4194},
	doi = {10.1126/science.1145194},
	url = {https://www.science.org/doi/10.1126/science.1145194},
	langid = {en}
}

@article{karlsson1995,
	title = {Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients},
	author = {Karlsson, P. and Smith, L. and Farde, L. and {Härnryd}, C. and Sedvall, G. and Wiesel, F. A.},
	year = {1995},
	month = {10},
	date = {1995-10},
	journal = {Psychopharmacology},
	pages = {309--316},
	volume = {121},
	number = {3},
	doi = {10.1007/BF02246068},
	note = {PMID: 8584611},
	langid = {eng}
}

@article{barr1993,
	title = {Alleles at the dopamine D4 receptor locus do not contribute to the genetic susceptibility to schizophrenia in a large Swedish kindred},
	author = {Barr, C. L. and Kennedy, J. L. and Lichter, J. B. and Van Tol, H. H. and Wetterberg, L. and Livak, K. J. and Kidd, K. K.},
	year = {1993},
	month = {12},
	date = {1993-12-15},
	journal = {American Journal of Medical Genetics},
	pages = {218--222},
	volume = {48},
	number = {4},
	doi = {10.1002/ajmg.1320480409},
	note = {PMID: 8135305},
	langid = {eng}
}

@article{rao1994,
	title = {Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine},
	author = {Rao, P. A. and Pickar, D. and Gejman, P. V. and Ram, A. and Gershon, E. S. and Gelernter, J.},
	year = {1994},
	month = {11},
	date = {1994-11},
	journal = {Archives of General Psychiatry},
	pages = {912--917},
	volume = {51},
	number = {11},
	doi = {10.1001/archpsyc.1994.03950110072009},
	note = {PMID: 7944879},
	langid = {eng}
}

@article{shaikh1995,
	title = {Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients},
	author = {Shaikh, S. and Collier, D. A. and Sham, P. and Pilowsky, L. and Sharma, T. and Lin, L. K. and Crocq, M. A. and Gill, M. and Kerwin, R.},
	year = {1995},
	month = {12},
	date = {1995-12-18},
	journal = {American Journal of Medical Genetics},
	pages = {541--545},
	volume = {60},
	number = {6},
	doi = {10.1002/ajmg.1320600611},
	note = {PMID: 8825892},
	langid = {eng}
}

@article{he2013,
	title = {The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain},
	author = {He, Meng and Deng, Chao and Huang, Xu-Feng},
	year = {2013},
	month = {06},
	date = {2013-06},
	journal = {CNS drugs},
	pages = {423--434},
	volume = {27},
	number = {6},
	doi = {10.1007/s40263-013-0062-1},
	note = {PMID: 23640535},
	langid = {eng}
}

@article{jarskog2015,
	title = {A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy},
	author = {Jarskog, L. Fredrik and Lowy, Martin T. and Grove, Richard A. and Keefe, Richard S. E. and Horrigan, Joseph P. and Ball, M. Patricia and Breier, Alan and Buchanan, Robert W. and Carter, Cameron S. and Csernansky, John G. and Goff, Donald C. and Green, Michael F. and Kantrowitz, Joshua T. and Keshavan, Matcheri S. and Laurelle, Marc and Lieberman, Jeffrey A. and Marder, Stephen R. and Maruff, Paul and McMahon, Robert P. and Seidman, Larry J. and Peykamian, Margaret A.},
	year = {2015},
	month = {05},
	date = {2015-05},
	journal = {Schizophrenia Research},
	pages = {136--142},
	volume = {164},
	number = {1-3},
	doi = {10.1016/j.schres.2015.01.041},
	note = {PMID: 25728831},
	langid = {eng}
}
